| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromo shadow domain binding | 4.59e-05 | 6 | 267 | 3 | GO:0070087 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | DCAF1 TSSK6 SLK OBSCN STK4 TLK1 CLK1 PLK3 WNK3 KALRN LMTK2 LATS2 MARK4 PRKCG MAPK4 | 1.20e-04 | 363 | 267 | 15 | GO:0106310 |
| GeneOntologyBiologicalProcess | chromatin organization | DCAF1 EPC2 ASXL1 TSSK6 PHF20 PIWIL1 GATA3 CHD2 KMT2E NSD3 JARID2 TLK1 BRCA2 SUPT6H MKI67 SHPRH KDM2B NIPBL UBR2 HIRIP3 EP400 CHAF1A SMC6 PPHLN1 BRD3 REST ZZZ3 CBX6 SETBP1 PAX7 | 1.70e-06 | 896 | 265 | 30 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | DCAF1 EPC2 ASXL1 TSSK6 PHF20 PIWIL1 GATA3 CHD2 KMT2E NSD3 JARID2 TLK1 BRCA2 SUPT6H TAF7L MKI67 SHPRH KDM2B MED26 NIPBL UBR2 HIRIP3 EP400 CHAF1A SMC6 PPHLN1 BRD3 REST ZZZ3 CBX6 SETBP1 PAX7 | 1.92e-06 | 999 | 265 | 32 | GO:0071824 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 MYF6 ASXL1 SP100 PHF20 C9orf78 UPF3A KMT2E JARID2 FZR1 R3HCC1L LDB1 BRCA2 SUPT6H TAF7L KDM2B PIP5K1A MED26 NIPBL RPA4 NCOA2 DDX12P AFF2 EP400 PHF12 TUT1 NUP214 POM121C PCF11 ATF6 CBX6 SSU72 RBMX2 SF3B6 DOCK7 NHEJ1 SLX4 HNRNPR MYBL2 | 4.95e-06 | 1377 | 275 | 39 | GO:0140513 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | CBLL1 DCAF1 EPC2 SPAG1 PDE3B PHF20 JADE3 CEP170 KLHL3 FZR1 FBXW8 AGO4 BRCA2 UBE3A TAF7L UBR2 EP400 EIF4H SESN3 CCT2 ZZZ3 CBX6 OTUD6B EIF4B DGKI NHEJ1 SLX4 | 2.16e-04 | 972 | 275 | 27 | GO:0140535 |
| GeneOntologyCellularComponent | chromatin | MYF6 EPC2 PHF20 JADE3 GATA3 CHD2 NKX2-6 KMT2E NSD3 JARID2 LDB1 SHPRH PDS5A NIPBL PLK3 NCOA2 UBR2 CUX2 DDX12P EP400 PHF12 CHAF1A ISX BRD3 REST ZFPM2 ATF6 ZZZ3 CBX6 ANKRD11 HSFX3 ELK1 PAX5 PAX7 LYL1 SLX4 | 2.65e-04 | 1480 | 275 | 36 | GO:0000785 |
| HumanPheno | Diagnostic behavioral phenotype | CDH23 CHD2 AHDC1 SYNGAP1 JARID2 NLGN3 FZR1 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 DNAJC13 AFF2 EIF4H ADAM22 ZFPM2 MADD DHX30 OTUD6B SETBP1 DOCK7 ANKRD11 AUTS2 ATP1A1 ATP1A3 GABBR1 | 7.59e-06 | 747 | 78 | 27 | HP:0025783 |
| HumanPheno | Autistic behavior | CHD2 AHDC1 SYNGAP1 JARID2 NLGN3 FZR1 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 AFF2 EIF4H ADAM22 ZFPM2 MADD DHX30 OTUD6B SETBP1 DOCK7 ANKRD11 AUTS2 ATP1A1 ATP1A3 GABBR1 | 1.35e-05 | 678 | 78 | 25 | HP:0000729 |
| HumanPheno | Hyperactivity | CHD2 SYNGAP1 JARID2 FZR1 BRCA2 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 AFF2 EIF4H ATP10A MADD SETBP1 ANKRD11 AUTS2 PRKCG ATP1A1 ATP1A3 GABBR1 HNRNPR | 1.88e-05 | 558 | 78 | 22 | HP:0000752 |
| HumanPheno | Abnormal thought pattern | CDH23 TULP1 SYNGAP1 JARID2 NLGN3 UBE3A NIPBL CACNA2D1 CUX2 AFF2 EIF4H MADD DHX30 USP8 DOCK7 AUTS2 GABBR1 HNRNPR | 2.61e-05 | 404 | 78 | 18 | HP:5200269 |
| HumanPheno | Disinhibition | CHD2 KMT2E TULP1 SYNGAP1 JARID2 NLGN3 FZR1 BRCA2 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 DNAJC13 AFF2 EIF4H ATP10A MADD SETBP1 ANKRD11 AUTS2 PRKCG ATP1A1 ATP1A3 GABBR1 HNRNPR | 9.37e-05 | 807 | 78 | 26 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CHD2 KMT2E TULP1 SYNGAP1 JARID2 NLGN3 FZR1 BRCA2 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 DNAJC13 AFF2 EIF4H ATP10A MADD SETBP1 ANKRD11 AUTS2 PRKCG ATP1A1 ATP1A3 GABBR1 HNRNPR | 9.37e-05 | 807 | 78 | 26 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CHD2 KMT2E TULP1 SYNGAP1 JARID2 NLGN3 FZR1 BRCA2 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 DNAJC13 AFF2 EIF4H ATP10A MADD SETBP1 ANKRD11 AUTS2 PRKCG ATP1A1 ATP1A3 GABBR1 HNRNPR | 9.37e-05 | 807 | 78 | 26 | HP:5200123 |
| HumanPheno | Social disinhibition | CHD2 KMT2E TULP1 SYNGAP1 JARID2 NLGN3 FZR1 BRCA2 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 DNAJC13 AFF2 EIF4H ATP10A MADD SETBP1 ANKRD11 AUTS2 PRKCG ATP1A1 ATP1A3 GABBR1 HNRNPR | 9.37e-05 | 807 | 78 | 26 | HP:5200029 |
| HumanPheno | Abnormal social development | CHD2 KMT2E TULP1 SYNGAP1 JARID2 NLGN3 FZR1 BRCA2 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 DNAJC13 AFF2 EIF4H ATP10A ADAM22 MADD SETBP1 DOCK7 ANKRD11 AUTS2 PRKCG ATP1A1 ATP1A3 GABBR1 HNRNPR | 9.80e-05 | 908 | 78 | 28 | HP:0025732 |
| HumanPheno | Restricted or repetitive behaviors or interests | TULP1 SYNGAP1 JARID2 NLGN3 UBE3A NIPBL CACNA2D1 CUX2 AFF2 EIF4H MADD DHX30 DOCK7 AUTS2 GABBR1 HNRNPR | 1.08e-04 | 368 | 78 | 16 | HP:0031432 |
| HumanPheno | Attention deficit hyperactivity disorder | CHD2 SYNGAP1 JARID2 FZR1 BRCA2 UBE3A NIPBL CACNA2D1 EIF4H MADD SETBP1 ANKRD11 AUTS2 PRKCG ATP1A3 GABBR1 HNRNPR | 1.24e-04 | 413 | 78 | 17 | HP:0007018 |
| HumanPheno | Recurrent maladaptive behavior | ASXL1 KIAA0319L CDH23 CHD2 KMT2E TULP1 SYNGAP1 JARID2 NLGN3 FZR1 BRCA2 ZNRF3 UBE3A ALDH5A1 NIPBL CACNA2D1 CUX2 DNAJC13 AFF2 EIF4H ATP10A MADD DHX30 USP8 PPP2R2B SETBP1 DOCK7 ANKRD11 AUTS2 PRKCG ATP1A1 ATP1A3 PALLD GABBR1 HNRNPR | 1.30e-04 | 1293 | 78 | 35 | HP:5200241 |
| HumanPheno | Perseverative thought | TULP1 SYNGAP1 JARID2 NLGN3 UBE3A NIPBL CACNA2D1 CUX2 AFF2 EIF4H MADD DHX30 DOCK7 AUTS2 GABBR1 HNRNPR | 1.43e-04 | 377 | 78 | 16 | HP:0030223 |
| HumanPheno | Disordered formal thought process | TULP1 SYNGAP1 JARID2 NLGN3 UBE3A NIPBL CACNA2D1 CUX2 AFF2 EIF4H MADD DHX30 DOCK7 AUTS2 GABBR1 HNRNPR | 1.89e-04 | 386 | 78 | 16 | HP:0025769 |
| MousePheno | decreased fetal size | PHF20 PATZ1 CHD2 SSR1 AHDC1 FBXW8 BRCA2 DHFR2 KDM2B PDS5A NIPBL SMC6 OTUD6B EIF4B | 6.77e-06 | 229 | 204 | 14 | MP:0004200 |
| MousePheno | abnormal fetal size | PHF20 PATZ1 CHD2 SSR1 AHDC1 FBXW8 BRCA2 DHFR2 KDM2B PDS5A NIPBL SMC6 OTUD6B EIF4B | 1.00e-05 | 237 | 204 | 14 | MP:0004198 |
| MousePheno | abnormal fetal growth/weight/body size | CELF4 PHF20 PATZ1 CHD2 SSR1 AHDC1 JARID2 FBXW8 BRCA2 DHFR2 KDM2B PDS5A NIPBL SMC6 OTUD6B EIF4B | 1.38e-05 | 312 | 204 | 16 | MP:0004197 |
| Domain | NPIP | 2.11e-08 | 14 | 265 | 6 | IPR009443 | |
| Domain | Znf_PHD | 6.54e-07 | 91 | 265 | 10 | IPR001965 | |
| Domain | ZF_PHD_2 | 9.78e-07 | 95 | 265 | 10 | PS50016 | |
| Domain | ZF_PHD_1 | 1.08e-06 | 96 | 265 | 10 | PS01359 | |
| Domain | Znf_FYVE_PHD | PHF20 JADE3 KMT2E NSD3 SHPRH KDM2B PHF12 DIDO1 SYTL3 PHF3 ZFYVE19 RIMS1 | 1.28e-06 | 147 | 265 | 12 | IPR011011 |
| Domain | Zinc_finger_PHD-type_CS | 3.71e-06 | 65 | 265 | 8 | IPR019786 | |
| Domain | PHD | 4.81e-06 | 89 | 265 | 9 | SM00249 | |
| Domain | Znf_CCHC | 1.21e-05 | 55 | 265 | 7 | IPR001878 | |
| Domain | ZnF_C2HC | 1.21e-05 | 55 | 265 | 7 | SM00343 | |
| Domain | Znf_PHD-finger | 1.62e-05 | 79 | 265 | 8 | IPR019787 | |
| Domain | - | CBLL1 PHF20 MARCHF10 JADE3 KMT2E NSD3 ZNRF3 SHPRH KDM2B PJA1 UBR2 PHF12 DIDO1 ZNF341 SYTL3 PHF3 TRIM17 ZFYVE19 RIMS1 | 2.42e-05 | 449 | 265 | 19 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | CBLL1 PHF20 MARCHF10 JADE3 KMT2E NSD3 ZNRF3 SHPRH KDM2B PJA1 UBR2 PHF12 DIDO1 ZNF341 SYTL3 PHF3 TRIM17 ZFYVE19 RIMS1 | 3.27e-05 | 459 | 265 | 19 | IPR013083 |
| Domain | - | CELF4 RBM12B UPF3A R3HCC1L CELF6 EIF4H POLDIP3 R3HCC1 TUT1 RBMX2 SF3B6 EIF4B HNRNPR | 4.85e-05 | 244 | 265 | 13 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | CELF4 RBM12B UPF3A R3HCC1L CELF6 EIF4H POLDIP3 R3HCC1 TUT1 RBMX2 SF3B6 EIF4B HNRNPR | 8.55e-05 | 258 | 265 | 13 | IPR012677 |
| Domain | PHD | 9.33e-05 | 75 | 265 | 7 | PF00628 | |
| Domain | - | 1.46e-04 | 36 | 265 | 5 | 2.60.200.20 | |
| Domain | FHA_dom | 1.46e-04 | 36 | 265 | 5 | IPR000253 | |
| Domain | SH3 | FNBP1 OBSCN NEB SH3YL1 CASKIN2 VAV3 MPP7 KALRN SH3GLB1 MYO15A HCLS1 | 2.72e-04 | 216 | 265 | 11 | PS50002 |
| Domain | SH3 | FNBP1 OBSCN NEB SH3YL1 CASKIN2 VAV3 MPP7 KALRN SH3GLB1 MYO15A HCLS1 | 2.72e-04 | 216 | 265 | 11 | SM00326 |
| Domain | SH3_domain | FNBP1 OBSCN NEB SH3YL1 CASKIN2 VAV3 MPP7 KALRN SH3GLB1 MYO15A HCLS1 | 3.19e-04 | 220 | 265 | 11 | IPR001452 |
| Domain | AT_hook | 5.38e-04 | 27 | 265 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 5.38e-04 | 27 | 265 | 4 | IPR017956 | |
| Domain | FHA | 6.20e-04 | 28 | 265 | 4 | SM00240 | |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 3.43e-17 | 25 | 283 | 11 | 17684299 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 ASXL1 GAPVD1 PHF20 C9orf78 CCNO B4GALT1 CEP170 STK4 FZR1 TLK1 MRPL16 SVIL MKI67 PDS5A TACC3 NIPBL KPNA2 CACNA2D1 EIF4H MRPS18B POLDIP3 CANX DCP2 SMC6 CCT2 NUP214 FAM83B DHX30 PCF11 PPP2R2A MISP PPP2R5C MAP1S HNRNPUL2 RBMX2 SF3B6 EIF4B DIXDC1 SLX4 HNRNPR MYBL2 | 4.80e-16 | 1155 | 283 | 42 | 20360068 |
| Pubmed | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.13e-15 | 23 | 283 | 10 | 18602769 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FNBP1 GAPVD1 JADE3 C9orf78 ZC3H13 REXO1 TLK1 SVIL ZBTB21 MKI67 OSBPL11 KDM2B TACC3 PRRC2A NIPBL DNAJC13 HIRIP3 EP400 PHF12 CHAF1A DIDO1 BRD3 NUP214 REST PNISR PCF11 MAP1S PHF3 RBMX2 EIF4B GZMB RIMS1 MYBL2 | 1.06e-14 | 774 | 283 | 33 | 15302935 |
| Pubmed | EPC2 ASXL1 SLK GATA3 FHAD1 LDB1 MRPL16 SVIL ZBTB21 MKI67 KDM2B SLX4IP PDS5A ZNF770 PRRC2A NIPBL NCOA2 EP400 NOP16 MRPS18B POLDIP3 PHF12 CANX ISX DIDO1 CCT2 NUP214 POM121C ZFPM2 DHX30 PCF11 PPP2R2A ZZZ3 HNRNPUL2 AUTS2 PAX7 ATP1A1 ZNF512 SLX4 HNRNPR MYBL2 | 2.60e-12 | 1429 | 283 | 41 | 35140242 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CBLL1 NES RBM12B ZC3H13 RPS9 CHD2 UPF3A SSR1 AHDC1 NSD3 SYNGAP1 CEP170 MRPL16 CLK1 SUPT6H PDS5A NIPBL KPNA2 DNAJC13 FYTTD1 EP400 KALRN POLDIP3 CANX DIDO1 BRD3 LYAR PNISR DHX30 PCF11 HNRNPUL2 RBMX2 SF3B6 DOCK7 HNRNPR | 4.58e-12 | 1082 | 283 | 35 | 38697112 |
| Pubmed | CBLL1 NES SLK PDE4A PATZ1 TRPC4 SYNGAP1 CEP170 NLGN3 LDB1 UBE3A SVIL ZBTB21 PPP1R3F TACC3 PRRC2A NIPBL WNK3 NCOA2 CACNA2D1 DNAJC13 KALRN CANX DIDO1 ADAM22 CELSR2 HNRNPUL2 DOCK7 DGKI PRKCG DIXDC1 RIMS1 | 2.04e-11 | 963 | 283 | 32 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES GAPVD1 PDE3B PATZ1 GAB2 NSD3 CEP170 STK4 CASKIN2 STARD9 SVIL CGN ZBTB21 WNK3 DCP2 LMTK2 MAGI3 MADD FAM83B USP8 NKD2 PHF3 EIF4B MARK4 DOCK7 ANKRD11 PRKCG FAM53B MAPK4 PALLD | 2.88e-11 | 861 | 283 | 30 | 36931259 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 EPC2 PHF20 JADE3 PATZ1 ZC3H13 CHD2 AHDC1 NSD3 SUPT6H MKI67 KDM2B PDS5A NIPBL KPNA2 FYTTD1 HIRIP3 EP400 NOP16 POLDIP3 PHF12 CHAF1A DIDO1 PPHLN1 BRD3 NUP214 REST LYAR POM121C PNISR MISP ZZZ3 PHF3 RBMX2 ANKRD11 HNRNPR MYBL2 | 3.74e-11 | 1294 | 283 | 37 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CBLL1 ZC3H13 NSD3 CEP170 BRCA2 MKI67 SLX4IP PDS5A PRRC2A NIPBL EP400 NOP16 POLDIP3 CHAF1A SMC6 DIDO1 PPHLN1 NUP214 LYAR PCF11 ZZZ3 DCD PHF3 EIF4B ANKRD11 RP9 ZNF512 SLX4 HNRNPR MYBL2 | 3.37e-10 | 954 | 283 | 30 | 36373674 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FNBP1 CPAMD8 MBTPS1 PDE3B OBSCN CHD2 AHDC1 B4GALT1 SH3YL1 CEP170 NLGN3 TLK1 TNRC18 LDB1 TULP4 SUPT6H EIF2B4 EXOC6B SHPRH SLX4IP PIP5K1A NCOA2 PITPNM2 UBR2 DNAJC13 FYTTD1 NEIL1 MAGI3 PPHLN1 ATP10A ATF6 PPP2R2A LATS2 SETBP1 ANKRD11 AUTS2 RIMS1 ZNF512 | 5.06e-10 | 1489 | 283 | 38 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE4A PCNX3 KIAA0319L OBSCN AHDC1 REXO1 NSD3 FZR1 TLK1 TNRC18 TULP4 ZNRF3 PLK3 SEMA3F PITPNM2 EP400 KALRN PHF12 LMTK2 TRMT1 NUP214 POM121C MADD DHX30 LATS2 CELSR2 MAP1S ZNF341 SSU72 MARK4 ANKRD11 MYBL2 | 6.44e-10 | 1105 | 283 | 32 | 35748872 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | PATZ1 ZC3H13 CDH23 CEP170 CLK1 ADAMTS18 PRRC2A DNAJC13 POLDIP3 DIDO1 PPHLN1 PNISR ATP10A PCF11 MAP1S PHF3 EIF4B PALLD | 1.29e-09 | 361 | 283 | 18 | 26167880 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | JADE3 C9orf78 CHD2 NSD3 ZBTB21 MKI67 SHPRH KDM2B PDS5A ZNF770 NIPBL KPNA2 HIRIP3 PHF12 CHAF1A SMC6 DIDO1 BRD3 LYAR PHF3 RBMX2 ZNF512 MYBL2 | 1.39e-09 | 608 | 283 | 23 | 36089195 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CBLL1 SP100 RBM12B ZC3H13 RPS9 NSD3 CEP170 FZR1 SVIL EIF2B4 CGN MKI67 KPNA2 NOP16 MRPS18B POLDIP3 CANX TUT7 DIDO1 PPHLN1 CCT2 LYAR ERLIN1 FAM83B DHX30 PPP2R2A MISP DCD HNRNPUL2 PHF3 EIF4B DOCK7 HNRNPR | 3.90e-09 | 1257 | 283 | 33 | 36526897 |
| Pubmed | Interaction network of human early embryonic transcription factors. | EPC2 AHDC1 TNRC18 LDB1 MKI67 KDM2B ALDH5A1 NIPBL NCOA2 EP400 PHF12 NUP214 POM121C ZZZ3 AUTS2 ATP1A1 SLX4 | 5.79e-09 | 351 | 283 | 17 | 38297188 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CBLL1 ASXL1 MBTPS1 C9orf78 ZC3H13 SSR1 LDB1 ECI2 PJA1 PRRC2A KPNA2 NCOA2 TANK EIF4H SPTLC1 CCT2 PNISR COA8 DHX30 DCD SF3B6 EIF4B DOCK7 ANKRD11 AUTS2 ATP1A1 HNRNPR | 1.21e-08 | 922 | 283 | 27 | 27609421 |
| Pubmed | CBLL1 PCNX3 CHD2 SSR1 AHDC1 NSD3 JARID2 SUPT6H KDM2B PDS5A PRRC2A NIPBL MPP7 FYTTD1 EP400 NOP16 MRPS18B PHF12 CHAF1A DIDO1 PPHLN1 BRD3 LYAR PNISR ERLIN1 FAM83B DHX30 PCF11 HABP4 PPP2R5C PHF3 RBMX2 SF3B6 EIF4B ANKRD11 | 2.37e-08 | 1497 | 283 | 35 | 31527615 | |
| Pubmed | NES GAPVD1 ZC3H13 CHD2 CEP170 SUPT6H CGN MKI67 PDS5A PRRC2A NIPBL POLDIP3 CANX TUT7 DIDO1 CCT2 NUP214 DHX30 PHF3 DOCK7 ATP1A1 ZNF512 | 2.56e-08 | 653 | 283 | 22 | 22586326 | |
| Pubmed | PATZ1 RPS9 GATA3 TNRC18 MKI67 ZNF770 PRRC2A KPNA2 NOP16 MRPS18B POLDIP3 NUP214 LYAR POM121C FAM83B DHX30 PPP2R2A MISP HNRNPUL2 RP9 ATP1A1 HNRNPR | 2.70e-08 | 655 | 283 | 22 | 35819319 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES GAPVD1 RBM12B RPS9 CEP170 FBXW8 SUPT6H SVIL CGN ZBTB21 MKI67 NIPBL KPNA2 CACNA2D1 EP400 EIF4H POLDIP3 CANX CCT2 NUP214 ERLIN1 FAM83B DHX30 HNRNPUL2 SF3B6 DOCK7 ATP1A1 HNRNPR | 2.74e-08 | 1024 | 283 | 28 | 24711643 |
| Pubmed | REXO1 BRCA2 SUPT6H ZBTB21 SLX4IP PDS5A NIPBL EP400 POLDIP3 PPHLN1 DHX30 SLX4 MYBL2 | 4.10e-08 | 222 | 283 | 13 | 37071664 | |
| Pubmed | DCAF1 FNBP1 ASXL1 MBTPS1 SLK STARD9 KIF17 UBR2 EP400 EIF4H NUP214 MADD DHX30 USP8 PHF3 MARK4 DOCK7 | 5.04e-08 | 407 | 283 | 17 | 12693553 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | CBLL1 SPAG1 ZC3H13 RPS9 SUPT6H STARD9 SVIL MKI67 KPNA2 MRPS18B PHF12 LMTK2 PPHLN1 FAM83B DHX30 MISP | 5.59e-08 | 361 | 283 | 16 | 30344098 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | CBLL1 DCAF1 SP100 GAPVD1 GATA3 CHD2 KMT2E B4GALT1 SYNGAP1 CLK1 MKI67 PDS5A RMND1 DNAJC13 CANX SMC6 SPTLC1 GOSR2 ERLIN1 ATF6 PPP2R5C NKD2 DCD PHF3 DOCK7 AUTS2 ATP1A1 ZNF512 SLX4 HNRNPR | 6.47e-08 | 1203 | 283 | 30 | 29180619 |
| Pubmed | GAPVD1 JADE3 MTSS1 AGO4 CASKIN2 SUPT6H ZBTB21 KDM2B PITPNM2 EP400 PHF12 LMTK2 DIDO1 PPP2R2A PPP2R5C SETBP1 AUTS2 FAM53B DIXDC1 | 8.80e-08 | 529 | 283 | 19 | 14621295 | |
| Pubmed | SSR1 MKI67 DNAJC13 REST ADAM22 MADD DHX30 SH3GLB1 RIMS1 GABBR1 | 1.06e-07 | 128 | 283 | 10 | 30995482 | |
| Pubmed | FNBP1 EPC2 C9orf78 AHDC1 CEP170 TLK1 TNRC18 ZBTB21 MKI67 PDS5A ZNF770 PRRC2A NIPBL NCOA2 EP400 EIF4H POLDIP3 PHF12 DIDO1 SPAG7 CCT2 PCF11 DCD SF3B6 EIF4B ATP1A1 HNRNPR MYBL2 | 1.27e-07 | 1103 | 283 | 28 | 34189442 | |
| Pubmed | GAPVD1 RPS9 UPF3A AHDC1 TNRC18 TULP4 SVIL CGN MKI67 KDM2B MED26 PRRC2A KPNA2 UBR2 FYTTD1 EIF4H NOP16 POLDIP3 CANX CCT2 NUP214 ERLIN1 FAM83B DHX30 PPP2R2A PHF3 EIF4B ATP1A1 ATP1A3 HNRNPR | 1.40e-07 | 1247 | 283 | 30 | 27684187 | |
| Pubmed | REXO1 CEP170 NLGN3 TLK1 TNRC18 TULP4 CGN PDS5A ZFP28 MAGI3 USP37 POM121C ATP10A PCF11 SH3GLB1 ZNF512 PALLD SLX4 | 1.52e-07 | 493 | 283 | 18 | 15368895 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP100 AHDC1 CEP170 TLK1 BRCA2 ZBTB21 SLX4IP PDS5A MED26 NCOA2 EP400 ZZZ3 PHF3 EIF4B PALLD SLX4 HNRNPR | 1.74e-07 | 444 | 283 | 17 | 34795231 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RBM12B ZC3H13 CHD2 SUPT6H SUPV3L1 PRRC2A KPNA2 FYTTD1 EIF4H NOP16 POLDIP3 CANX TUT7 DIDO1 PPHLN1 LYAR PNISR DHX30 HNRNPUL2 SF3B6 EIF4B RP9 HNRNPR | 2.46e-07 | 807 | 283 | 23 | 22681889 |
| Pubmed | CHD2 NSD3 UBE3A SUPT6H ZBTB21 MKI67 PDS5A MED26 NIPBL EP400 EIF4H POLDIP3 CHAF1A SMC6 DIDO1 PPHLN1 CCT2 BRD3 LYAR PPP2R2A HNRNPUL2 SSU72 PHF3 AKR1C3 MYO15A NHEJ1 | 3.04e-07 | 1014 | 283 | 26 | 32416067 | |
| Pubmed | EPC2 SLK JADE3 C9orf78 SSR1 NSD3 CEP170 SHPRH PIP5K1A MED26 NCOA2 HIRIP3 EP400 EIF4H CHAF1A SMC6 SPAG7 BRD3 DOCK7 ZNF512 | 4.18e-07 | 645 | 283 | 20 | 25281560 | |
| Pubmed | SP100 CEP170 SVIL MKI67 PRRC2A NOP16 POLDIP3 PPHLN1 NUP214 LYAR POM121C DHX30 DOCK7 ZNF512 | 6.94e-07 | 332 | 283 | 14 | 25693804 | |
| Pubmed | GAPVD1 SLK NSD3 CEP170 CGN OSBPL11 KDM2B TACC3 PRRC2A KPNA2 NCOA2 EP400 DIDO1 CCT2 ZZZ3 PHF3 DOCK7 PALLD | 7.26e-07 | 549 | 283 | 18 | 38280479 | |
| Pubmed | MYF6 OBSCN CHD2 NEB KMT2E CEP170 CLK1 SUPT6H MLF1 KALRN PPHLN1 SH3GLB1 EIF4B PAX7 ATP1A1 PALLD HNRNPR | 8.34e-07 | 497 | 283 | 17 | 23414517 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GAPVD1 SLK RPS9 CEP170 STK4 R3HCC1L ZBTB21 MKI67 OSBPL11 PRRC2A NIPBL EP400 EIF4H POLDIP3 DIDO1 SPAG7 CCT2 NUP214 POM121C DHX30 USP8 EIF4B ATP1A1 PALLD | 8.51e-07 | 934 | 283 | 24 | 33916271 |
| Pubmed | FNBP1 ZC3H13 MKI67 OSBPL11 TACC3 PRRC2A NIPBL KPNA2 HIRIP3 KALRN CHAF1A TRMT1 DIDO1 PPHLN1 HNRNPUL2 PHF3 PALLD | 9.82e-07 | 503 | 283 | 17 | 16964243 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | CHD2 NSD3 SHPRH PIP5K1A PDS5A PRRC2A HIRIP3 EP400 POLDIP3 DIDO1 CCT2 BRD3 LYAR ATP1A1 ZNF512 | 1.00e-06 | 394 | 283 | 15 | 27248496 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ASXL1 MARCHF10 CHD2 NEB CLK1 TAF7L PPP1R3F KPNA2 HIRIP3 EP400 NOP16 DIDO1 PPHLN1 BRD3 PPP2R2A PHF3 ATP1A1 MAPK4 JHY HNRNPR | 1.32e-06 | 695 | 283 | 20 | 23602568 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SLK C9orf78 RPS9 SSR1 CEP170 SUPT6H EIF2B4 PDS5A ECI2 PRRC2A NIPBL KPNA2 NOP16 MRPS18B CANX TRMT1 DIDO1 CCT2 LYAR DHX30 USP8 PPP2R2A MAP1S DCD OTUD6B SF3B6 EIF4B ATP1A1 PALLD HNRNPR | 1.92e-06 | 1415 | 283 | 30 | 28515276 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RBM12B RPS9 CLK1 MKI67 PRRC2A KPNA2 FYTTD1 MRPS18B POLDIP3 CANX PPHLN1 CCT2 MADD DHX30 PPP2R2A HNRNPUL2 SF3B6 EIF4B ATP1A1 HNRNPR | 1.99e-06 | 714 | 283 | 20 | 28302793 |
| Pubmed | RBM12B RPS9 SSR1 BRCA2 SVIL MKI67 SLX4IP PDS5A NIPBL CHAF1A CANX DIDO1 LYAR ERLIN1 MISP DCD HNRNPUL2 SF3B6 HNRNPR | 2.04e-06 | 652 | 283 | 19 | 31180492 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 NES RBM12B RPS9 SUPT6H MKI67 KPNA2 FYTTD1 NOP16 CHAF1A CANX TRMT1 DIDO1 PPHLN1 CCT2 LYAR ERLIN1 DHX30 DCD PHF3 SF3B6 EIF4B ATP1A1 HNRNPR | 2.29e-06 | 989 | 283 | 24 | 36424410 |
| Pubmed | FNBP1 SP100 RPS9 GATA3 LDB1 SUPT6H CHAF1A CCT2 PPP2R2A ATP1A1 | 2.85e-06 | 183 | 283 | 10 | 36129980 | |
| Pubmed | CHD2 CEP170 STARD9 SVIL EIF2B4 CGN MKI67 PRRC2A FYTTD1 EP400 NOP16 MRPS18B POLDIP3 TUT7 DCP2 DIDO1 PPHLN1 LYAR ERLIN1 PCF11 HABP4 DCD PHF3 RBMX2 SF3B6 DOCK7 AKR1C3 ATP1A1 MAJIN | 3.01e-06 | 1371 | 283 | 29 | 36244648 | |
| Pubmed | FNBP1 ZC3H13 SSR1 AHDC1 EVI5 MRPL16 UBE3A PIP5K1A MPP7 DNAJC13 PPHLN1 BRD3 FAM83B EIF4B | 3.17e-06 | 378 | 283 | 14 | 34315543 | |
| Pubmed | ASXL1 TULP1 BRCA2 TULP4 MKI67 AFF2 CHAF1A PANX2 CELSR2 RIMS1 PAX7 GABBR1 HNRNPR | 3.54e-06 | 329 | 283 | 13 | 17474147 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | GAPVD1 CEP170 SUPT6H MKI67 KPNA2 EP400 TUT7 LMTK2 NUP214 POM121C DHX30 PCF11 HNRNPUL2 PHF3 SLX4 | 3.87e-06 | 440 | 283 | 15 | 34244565 |
| Pubmed | 4.03e-06 | 14 | 283 | 4 | 28981838 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | RPS9 OBSCN SSR1 KPNA2 CANX PANX2 ATP10A DHX30 HNRNPUL2 SF3B6 EIF4B ATP1A1 HNRNPR | 4.04e-06 | 333 | 283 | 13 | 32665550 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 GAPVD1 SPAG1 PATZ1 CDH23 GAB2 TULP1 CEP170 STK4 TLK1 EIF2B4 CGN ZBTB21 EXOC6B MLF1 DNAJC13 SMC6 POM121C ERLIN1 DHX30 USP8 PPP2R2A PPP2R5C SH3GLB1 SF3B6 DOCK7 FAM53B DNAAF1 | 4.34e-06 | 1321 | 283 | 28 | 27173435 |
| Pubmed | RBM12B BRCA2 SUPT6H MKI67 SHPRH KDM2B KPNA2 SEMA3F HIRIP3 EP400 CANX SMC6 SPTLC1 DIDO1 NUP214 USP8 MISP SSU72 EIF4B HCLS1 | 4.49e-06 | 754 | 283 | 20 | 35906200 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RBM12B RPS9 CEP170 EIF2B4 MKI67 PRRC2A KPNA2 DNAJC13 FYTTD1 MRPS18B POLDIP3 TUT7 SMC6 DIDO1 LYAR DHX30 HNRNPUL2 PHF3 ZNF512 HNRNPR | 4.95e-06 | 759 | 283 | 20 | 35915203 |
| Pubmed | 5.27e-06 | 5 | 283 | 3 | 17529992 | ||
| Pubmed | FNBP1 WDR64 CHD2 SSR1 NEB KLHL3 UBE3A KDM2B NIPBL NCOA2 PHF12 POM121C USP8 PPP2R2B PHACTR3 DNAAF1 ZNF512 MYBL2 | 5.92e-06 | 638 | 283 | 18 | 31182584 | |
| Pubmed | CELF4 RBM12B PIWIL1 KLHL3 AGO4 SUPT6H CELF6 POLDIP3 TUT1 DHX30 RBMX2 SF3B6 HNRNPR | 6.30e-06 | 347 | 283 | 13 | 16033648 | |
| Pubmed | GAPVD1 C9orf78 KIAA0319L GAB2 EIF2B4 MKI67 PDS5A PJA1 TACC3 DNAJC13 AFF2 HIRIP3 EFCAB6 EP400 SMC6 CCT2 FAM83B PCF11 DOCK7 ATP1A1 | 6.98e-06 | 777 | 283 | 20 | 35844135 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NES SPAG1 SLK RPS9 SSR1 CEP170 SUPV3L1 PIP5K1A TACC3 ALDH5A1 KPNA2 DNAJC13 EIF4H MRPS18B POLDIP3 CANX TRMT1 CCT2 NUP214 ERLIN1 PPP2R2A MISP DCD SF3B6 EIF4B ZFYVE19 ATP1A1 PALLD | 8.18e-06 | 1367 | 283 | 28 | 32687490 |
| Pubmed | CBLL1 CHD2 AHDC1 JARID2 SUPT6H PDS5A KPNA2 EP400 NOP16 CHAF1A BRD3 NUP214 REST LYAR ZFPM2 | 8.30e-06 | 469 | 283 | 15 | 27634302 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | BRCA2 MKI67 SLX4IP KPNA2 EP400 DIDO1 CCT2 NUP214 PPP2R2A ZZZ3 NKD2 ATP1A1 SLX4 | 8.54e-06 | 357 | 283 | 13 | 37059091 |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 8.64e-06 | 59 | 283 | 6 | 16083285 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FNBP1 EPC2 ASXL1 GAPVD1 ZNF268 PATZ1 FBXW8 LDB1 ZBTB21 PDS5A KPNA2 NCOA2 UBR2 EP400 CHAF1A LENG9 ATF6 HNRNPUL2 SSU72 NHEJ1 MYBL2 | 8.65e-06 | 857 | 283 | 21 | 25609649 |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 FAM90A9 FAM90A8 FAM90A10 | 8.68e-06 | 164 | 283 | 9 | 22967998 |
| Pubmed | GAPVD1 CEP170 CLK1 SVIL CGN ZBTB21 SHPRH CCT2 USP37 USP8 DOCK7 | 8.83e-06 | 255 | 283 | 11 | 15324660 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | PHF20 AHDC1 STK4 JARID2 TLK1 SVIL OSBPL11 PRRC2A NIPBL KPNA2 DNAJC13 REST EIF4B ANKRD11 NHEJ1 MYBL2 | 9.81e-06 | 536 | 283 | 16 | 15840001 |
| Pubmed | PHF20 AHDC1 STK4 JARID2 TLK1 SVIL OSBPL11 PRRC2A NIPBL KPNA2 DNAJC13 REST EIF4B ANKRD11 NHEJ1 MYBL2 | 1.03e-05 | 538 | 283 | 16 | 10512203 | |
| Pubmed | 1.05e-05 | 6 | 283 | 3 | 31941533 | ||
| Pubmed | CHD2 is Required for Embryonic Neurogenesis in the Developing Cerebral Cortex. | 1.05e-05 | 6 | 283 | 3 | 25786798 | |
| Pubmed | DOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis. | 1.05e-05 | 6 | 283 | 3 | 22842144 | |
| Pubmed | FNBP1 GAPVD1 ZC3H13 OBSCN CHD2 NLGN3 ALDH1L2 OSBPL11 ADAMTS18 PJA1 NCOA2 FYTTD1 TUT7 SMC6 LMTK2 DIDO1 ERLIN1 MADD PPP2R5C ZNF341 EIF4B AKR1C3 SLX4 NCKAP1L | 1.06e-05 | 1084 | 283 | 24 | 11544199 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KMT2E SYNGAP1 TNRC18 TULP4 KPNA2 CUX2 AFF2 EP400 NUP214 POM121C MAP1S SETBP1 HSH2D PAX7 | 1.36e-05 | 430 | 283 | 14 | 35044719 |
| Pubmed | AHDC1 TNRC18 LDB1 ZBTB21 KDM2B NIPBL NCOA2 EP400 PHF12 PCF11 PHF3 | 1.41e-05 | 268 | 283 | 11 | 33640491 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ASXL1 PHF20 SSR1 AHDC1 JARID2 FBXW8 KDM2B PPP1R3F CHAF1A DIDO1 CCT2 ZZZ3 CBX6 AUTS2 MYBL2 | 1.56e-05 | 495 | 283 | 15 | 27705803 |
| Pubmed | EPC2 GAPVD1 NSD3 TNRC18 CASKIN2 SVIL ZBTB21 POLDIP3 CHAF1A CANX CCT2 TUT1 LENG9 MADD NKD2 PHF3 ZFYVE19 DGKI | 1.66e-05 | 689 | 283 | 18 | 36543142 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GAPVD1 SLK RPS9 SSR1 JARID2 SUPT6H STARD9 SUPV3L1 MKI67 PDS5A NIPBL KPNA2 POLDIP3 CHAF1A CANX SMC6 SPTLC1 CCT2 NUP214 LYAR DHX30 PPP2R2A DCD HNRNPUL2 DOCK7 ATP1A1 ZNF512 HNRNPR | 1.74e-05 | 1425 | 283 | 28 | 30948266 |
| Pubmed | NES SLK RPS9 SYNGAP1 CEP170 STK4 NLGN3 SVIL PRRC2A PITPNM2 CACNA2D1 DNAJC13 KALRN CCT2 ADAM22 MADD DHX30 PPP2R2A MISP MAP1S HNRNPUL2 EIF4B DOCK7 PRKCG RIMS1 ATP1A1 ATP1A3 HNRNPR | 1.87e-05 | 1431 | 283 | 28 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 NES RPS9 CHD2 STK4 UBE3A SUPV3L1 EIF2B4 MKI67 PDS5A NIPBL DNAJC13 EP400 EIF4H POLDIP3 TUT7 CCT2 NUP214 LYAR ERLIN1 DHX30 DCD HNRNPUL2 SF3B6 ZNF512 PALLD HNRNPR | 1.89e-05 | 1353 | 283 | 27 | 29467282 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GAPVD1 PDS5A NIPBL KPNA2 EP400 CHAF1A DIDO1 CCT2 NUP214 PHF3 PALLD HNRNPR | 2.04e-05 | 332 | 283 | 12 | 32786267 |
| Pubmed | DCAF1 GAPVD1 GATA3 CEP170 JARID2 FBXW8 BRCA2 SVIL MKI67 PDS5A ALDH5A1 UBR2 ERLIN1 FAM83B DHX30 HNRNPUL2 HNRNPR | 2.06e-05 | 634 | 283 | 17 | 34591612 | |
| Pubmed | SP100 SPAG1 CCNO CHD2 NEB TLK1 TNRC18 STARD9 ZBTB21 NIPBL CUX2 CCDC185 CHAF1A MAGI3 CCT2 BRD3 PNISR ERLIN1 PCF11 USP8 LATS2 RBMX2 EIF4B RIMS1 ATP1A1 ATP1A3 HCLS1 HNRNPR | 2.15e-05 | 1442 | 283 | 28 | 35575683 | |
| Pubmed | KIAA0319L SYNC SH3YL1 SYNGAP1 LDB1 UBE3A CLK1 SUPV3L1 PJA1 ALDH5A1 PRRC2A NIPBL NCOA2 KALRN SESN3 MAGI3 CCT2 PNISR ADAM22 MADD DHX30 USP8 ATF6 MAP1S AKR1C3 SLX4 | 2.15e-05 | 1285 | 283 | 26 | 35914814 | |
| Pubmed | GATA3 LDB1 MKI67 PJA1 TACC3 NCOA2 CUX2 EIF4H TUT7 ZFP28 DIDO1 BRD3 TUT1 REST ZZZ3 PAX5 PAX7 MYBL2 | 2.42e-05 | 709 | 283 | 18 | 22988430 | |
| Pubmed | SLK SSR1 NSD3 CEP170 MKI67 PIP5K1A PDS5A NIPBL KPNA2 CACNA2D1 DNAJC13 CANX SPTLC1 DIDO1 CCT2 NUP214 GOSR2 ERLIN1 DHX30 ATF6 MISP MAP1S EIF4B RP9 ATP1A1 PALLD | 2.51e-05 | 1297 | 283 | 26 | 33545068 | |
| Pubmed | 2.86e-05 | 107 | 283 | 7 | 11347906 | ||
| Pubmed | 2.90e-05 | 8 | 283 | 3 | 11956189 | ||
| Pubmed | 2.90e-05 | 8 | 283 | 3 | 17245430 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SLK CEP170 DHFR2 MKI67 PIP5K1A ECI2 PRRC2A DNAJC13 EIF4H SMC6 PPP2R2A PHF3 EIF4B DOCK7 ATP1A1 ZNF512 PALLD HNRNPR | 3.18e-05 | 724 | 283 | 18 | 36232890 |
| Pubmed | MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. | 3.36e-05 | 23 | 283 | 4 | 20332121 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPS9 SSR1 SVIL MKI67 KPNA2 NOP16 MRPS18B POLDIP3 CANX CCT2 LYAR DHX30 MISP DCD HNRNPUL2 RBMX2 EIF4B DOCK7 RP9 ATP1A1 HNRNPR | 3.87e-05 | 949 | 283 | 21 | 36574265 |
| Pubmed | 4.32e-05 | 9 | 283 | 3 | 18432318 | ||
| Pubmed | 4.32e-05 | 9 | 283 | 3 | 28705869 | ||
| Pubmed | Pax3/Pax7 mark a novel population of primitive myogenic cells during development. | 4.32e-05 | 9 | 283 | 3 | 15964993 | |
| Pubmed | Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. | 4.32e-05 | 9 | 283 | 3 | 22284184 | |
| Pubmed | 4.67e-05 | 157 | 283 | 8 | 30186101 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 5.67e-05 | 208 | 283 | 9 | 33230847 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | MYF6 SP100 PHF20 ZNF268 PATZ1 GATA3 NKX2-6 CUX2 ISX ZKSCAN2 REST ZFPM2 ATF6 ZZZ3 SETBP1 ELK1 PAX5 PAX7 LYL1 MYBL2 | 6.31e-05 | 908 | 283 | 20 | 19274049 |
| Pubmed | Protein translation rate determines neocortical neuron fate. | 6.50e-05 | 27 | 283 | 4 | 38849354 | |
| Pubmed | GAPVD1 PDE3B CASKIN2 SVIL MKI67 CANX POM121C FAM83B LATS2 NKD2 | 6.56e-05 | 263 | 283 | 10 | 34702444 | |
| Interaction | SNRNP40 interactions | CBLL1 JADE3 RBM12B C9orf78 ZC3H13 ACP5 AHDC1 NSD3 FZR1 TLK1 FBXW8 BRCA2 SUPT6H ZBTB21 MKI67 EP400 POLDIP3 PHF12 CCT2 USP37 POM121C PNISR HNRNPUL2 SF3B6 RP9 ZNF512 MYBL2 | 8.32e-08 | 637 | 263 | 27 | int:SNRNP40 |
| Interaction | SLX4 interactions | REXO1 BRCA2 SUPT6H ZBTB21 MKI67 SLX4IP PDS5A NIPBL RPA4 PLK3 KPNA2 EP400 POLDIP3 DIDO1 PPHLN1 CCT2 NUP214 DHX30 PPP2R2A ZZZ3 NKD2 DCD ATP1A1 SLX4 MYBL2 | 1.45e-07 | 572 | 263 | 25 | int:SLX4 |
| Interaction | SRPK2 interactions | MARCHF10 ZC3H13 CHD2 CEP170 CLK1 SUPT6H TAF7L MKI67 ADAMTS18 PRRC2A HIRIP3 NOP16 NEIL1 MRPS18B POLDIP3 DIDO1 PPHLN1 BRD3 LYAR PNISR DHX30 PCF11 MAP1S HNRNPUL2 CBX6 RBMX2 EIF4B PALLD | 2.55e-07 | 717 | 263 | 28 | int:SRPK2 |
| Interaction | H2BC21 interactions | EPC2 JADE3 OBSCN NEB NSD3 STK4 SUPT6H SVIL MKI67 SHPRH PRRC2A NIPBL DNAJC13 HIRIP3 EP400 PHF12 CHAF1A DIDO1 PPHLN1 REST USP8 ZZZ3 LATS2 CBX6 PHF3 ZNF512 HCLS1 | 4.82e-07 | 696 | 263 | 27 | int:H2BC21 |
| Interaction | TPX2 interactions | C9orf78 FZR1 SVIL MKI67 PRRC2A RPA4 KPNA2 POLDIP3 DIDO1 BRD3 PHF3 RP9 SLX4 HNRNPR | 5.10e-07 | 204 | 263 | 14 | int:TPX2 |
| Interaction | TERF2IP interactions | SP100 C9orf78 NSD3 BRCA2 SUPT6H ZBTB21 MKI67 KDM2B SLX4IP PDS5A NIPBL NCOA2 EP400 EIF4H CHAF1A DIDO1 SPAG7 PCF11 ZZZ3 PHF3 ANKRD11 SLX4 MYBL2 | 1.07e-06 | 552 | 263 | 23 | int:TERF2IP |
| Interaction | SSRP1 interactions | ASXL1 JADE3 ZC3H13 CHD2 UPF3A REXO1 BRCA2 SUPT6H PRRC2A NIPBL RPA4 FYTTD1 HIRIP3 CHAF1A LMTK2 DIDO1 PPHLN1 BRD3 LYAR PCF11 HNRNPUL2 PHF3 ANKRD11 ATP1A3 ZNF512 HNRNPR | 1.19e-06 | 685 | 263 | 26 | int:SSRP1 |
| Interaction | KLF8 interactions | EPC2 FHAD1 KDM2B PRRC2A NIPBL NCOA2 EP400 NOP16 MRPS18B PHF12 CANX POM121C PPP2R2A ZZZ3 HNRNPUL2 ZNF512 MYBL2 | 1.67e-06 | 329 | 263 | 17 | int:KLF8 |
| Interaction | H1-4 interactions | ASXL1 SP100 PATZ1 RPS9 CCNO NEB SYNGAP1 TNRC18 UBE3A SVIL ZNF770 ECI2 RPA4 FYTTD1 HIRIP3 NOP16 MRPS18B TUT7 CCT2 DHX30 ZNF341 PHF3 RBMX2 ZNF512 MYBL2 | 1.80e-06 | 656 | 263 | 25 | int:H1-4 |
| Interaction | MECP2 interactions | CBLL1 NES SP100 RBM12B ZC3H13 RPS9 CHD2 UPF3A SSR1 AHDC1 NSD3 SYNGAP1 CEP170 MRPL16 CLK1 SUPT6H MKI67 PDS5A NIPBL KPNA2 DNAJC13 FYTTD1 EP400 NOP16 KALRN POLDIP3 CANX DIDO1 BRD3 LYAR PNISR DHX30 PCF11 HNRNPUL2 RBMX2 SF3B6 DOCK7 HNRNPR | 2.00e-06 | 1287 | 263 | 38 | int:MECP2 |
| Interaction | YWHAH interactions | NES GAPVD1 PDE3B ZC3H13 GAB2 NSD3 SYNGAP1 CEP170 STK4 FZR1 CASKIN2 UBE3A STARD9 SVIL CGN ZBTB21 WNK3 NCOA2 LMTK2 MAGI3 PPHLN1 MADD FAM83B USP8 LATS2 NKD2 PHF3 EIF4B MARK4 DOCK7 ANKRD11 FAM53B RIMS1 PALLD | 2.86e-06 | 1102 | 263 | 34 | int:YWHAH |
| Interaction | EZH1 interactions | 3.24e-06 | 92 | 263 | 9 | int:EZH1 | |
| Interaction | TMA16 interactions | 4.23e-06 | 95 | 263 | 9 | int:TMA16 | |
| Interaction | GAGE5 interactions | 4.82e-06 | 52 | 263 | 7 | int:GAGE5 | |
| Interaction | ANAPC15 interactions | 7.10e-06 | 128 | 263 | 10 | int:ANAPC15 | |
| Interaction | SMC5 interactions | CBLL1 ZC3H13 NSD3 CEP170 BRCA2 MKI67 SLX4IP PDS5A PJA1 PRRC2A NIPBL EP400 NOP16 POLDIP3 CHAF1A SMC6 DIDO1 PPHLN1 NUP214 LYAR PCF11 ZZZ3 DCD PHF3 EIF4B ANKRD11 RP9 ZNF512 SLX4 HNRNPR MYBL2 | 7.41e-06 | 1000 | 263 | 31 | int:SMC5 |
| Interaction | H2BC8 interactions | EPC2 JADE3 C9orf78 NSD3 MKI67 KDM2B PDS5A NIPBL UBR2 HIRIP3 EP400 EIF4H MRPS18B CHAF1A DIDO1 SPAG7 BRD3 LYAR PHF3 RP9 ZNF512 MYBL2 | 7.44e-06 | 576 | 263 | 22 | int:H2BC8 |
| Interaction | RNF113A interactions | PATZ1 RPS9 GATA3 TNRC18 MKI67 ZNF770 PRRC2A KPNA2 NOP16 MRPS18B POLDIP3 CANX NUP214 LYAR POM121C FAM83B DHX30 PPP2R2A MISP HNRNPUL2 EIF4B RP9 ATP1A1 HNRNPR | 1.42e-05 | 692 | 263 | 24 | int:RNF113A |
| Interaction | CBX3 interactions | SP100 JADE3 C9orf78 ZC3H13 AHDC1 NSD3 ZBTB21 MKI67 KDM2B PDS5A NIPBL EP400 CHAF1A SPAG7 BRD3 REST USP37 CBX6 PHF3 RP9 ZNF512 SLX4 MYBL2 | 1.43e-05 | 646 | 263 | 23 | int:CBX3 |
| Interaction | YWHAG interactions | GAPVD1 PDE3B SLK ZC3H13 GAB2 SYNGAP1 CEP170 STK4 FZR1 CASKIN2 UBE3A CLK1 STARD9 SVIL CGN ZBTB21 SHPRH BNIP5 CHAF1A DCP2 LMTK2 MAGI3 CCT2 USP37 FAM83B USP8 LATS2 NKD2 PHF3 EIF4B MARK4 DOCK7 ANKRD11 PRKCG FAM53B | 1.60e-05 | 1248 | 263 | 35 | int:YWHAG |
| Interaction | AR interactions | ASXL1 PATZ1 RPS9 AHDC1 SH3YL1 FZR1 TNRC18 LDB1 UBE3A SVIL CGN ZBTB21 KDM2B PDS5A VAV3 NIPBL KPNA2 NCOA2 EFCAB6 EP400 PHF12 DIDO1 BRD3 PCF11 PPP2R2A LATS2 HNRNPUL2 PHF3 HSH2D HNRNPR | 1.69e-05 | 992 | 263 | 30 | int:AR |
| Interaction | HDAC1 interactions | DCAF1 FNBP1 MBTPS1 GAPVD1 C9orf78 GATA3 SSR1 KMT2E FZR1 TNRC18 BRCA2 ZBTB21 MKI67 KDM2B TACC3 KPNA2 DNAJC13 EFCAB6 EP400 PHF12 CHAF1A CCT2 NUP214 REST USP37 ZFPM2 PPP2R2A ZZZ3 LATS2 DOCK7 ELK1 HNRNPR | 2.16e-05 | 1108 | 263 | 32 | int:HDAC1 |
| Interaction | IFI27L1 interactions | 2.17e-05 | 65 | 263 | 7 | int:IFI27L1 | |
| Interaction | POLR1G interactions | JADE3 C9orf78 TRPC4 RPS9 CHD2 NSD3 SUPT6H KDM2B PDS5A NIPBL KPNA2 EP400 CHAF1A BRD3 LYAR PHF3 RBMX2 ANKRD11 ZNF512 | 2.51e-05 | 489 | 263 | 19 | int:POLR1G |
| Interaction | H3C3 interactions | JADE3 C9orf78 NSD3 SUPT6H MKI67 SHPRH KDM2B PDS5A NIPBL KPNA2 PHF12 CHAF1A SMC6 DIDO1 BRD3 LYAR PHF3 RBMX2 ZNF512 | 2.96e-05 | 495 | 263 | 19 | int:H3C3 |
| Interaction | KLF15 interactions | EPC2 MRPL16 KDM2B PRRC2A NIPBL NCOA2 EP400 NOP16 MRPS18B PHF12 DHX30 HNRNPUL2 ZNF512 MYBL2 | 2.98e-05 | 290 | 263 | 14 | int:KLF15 |
| Interaction | SUMO2 interactions | SP100 GAPVD1 ZBTB21 MKI67 SLX4IP PDS5A NIPBL KPNA2 TANK EP400 KALRN CHAF1A DIDO1 CCT2 BRD3 NUP214 DCD PHF3 PALLD SLX4 HNRNPR | 3.50e-05 | 591 | 263 | 21 | int:SUMO2 |
| Interaction | CLEC11A interactions | 3.72e-05 | 96 | 263 | 8 | int:CLEC11A | |
| Interaction | SUZ12 interactions | CBLL1 C9orf78 ZC3H13 CHD2 AHDC1 JARID2 MKI67 SHPRH PDS5A PJA1 KPNA2 FYTTD1 EP400 CHAF1A CANX NUP214 REST ERLIN1 DHX30 LATS2 SF3B6 MYBL2 | 4.10e-05 | 644 | 263 | 22 | int:SUZ12 |
| Interaction | SIRT7 interactions | DCAF1 NES GAPVD1 ZC3H13 CHD2 CEP170 SUPT6H CGN MKI67 PDS5A PRRC2A NIPBL POLDIP3 CANX TUT7 DIDO1 CCT2 NUP214 LYAR DHX30 PHF3 DOCK7 ATP1A1 ZNF512 | 4.54e-05 | 744 | 263 | 24 | int:SIRT7 |
| Interaction | YWHAZ interactions | ASXL1 GAPVD1 PDE3B SLK NEB GAB2 SYNGAP1 CEP170 FZR1 LDB1 UBE3A STARD9 SVIL CGN ZBTB21 MLF1 PRRC2A BNIP5 CHAF1A BRD3 ADAM22 MADD FAM83B USP8 PPP2R5C LATS2 NKD2 PHF3 EIF4B MARK4 DOCK7 ZFYVE19 FAM53B ATP1A1 GABBR1 | 5.02e-05 | 1319 | 263 | 35 | int:YWHAZ |
| Interaction | H3C1 interactions | DCAF1 TSSK6 PHF20 C9orf78 RPS9 NEB NSD3 TLK1 TNRC18 MKI67 SHPRH KDM2B PDS5A NIPBL CHAF1A SMC6 DIDO1 SPAG7 CCT2 BRD3 HNRNPUL2 CBX6 PHF3 PAX5 ZNF512 PALLD JHY | 5.34e-05 | 901 | 263 | 27 | int:H3C1 |
| Interaction | TNIP2 interactions | CBLL1 ASXL1 MBTPS1 C9orf78 ZC3H13 SSR1 LDB1 CLK1 MLF1 ECI2 PJA1 PRRC2A NCOA2 TANK EIF4H SPTLC1 CCT2 PNISR COA8 DHX30 DCD SF3B6 EIF4B DOCK7 ANKRD11 AUTS2 ATP1A1 HNRNPR | 5.34e-05 | 952 | 263 | 28 | int:TNIP2 |
| Interaction | CAPN10 interactions | 5.50e-05 | 32 | 263 | 5 | int:CAPN10 | |
| Interaction | SRSF5 interactions | RPS9 FZR1 MRPL16 CLK1 MKI67 ZNF770 NOP16 NEIL1 MRPS18B MAGI3 REST LYAR DHX30 CBX6 RBMX2 SF3B6 ZNF512 HNRNPR | 5.51e-05 | 474 | 263 | 18 | int:SRSF5 |
| Interaction | DDX23 interactions | SLK JADE3 C9orf78 ZC3H13 CHD2 CLK1 SUPT6H PDS5A KPNA2 POLDIP3 PPHLN1 LYAR PNISR PHF3 RBMX2 ANKRD11 RP9 HNRNPR | 6.48e-05 | 480 | 263 | 18 | int:DDX23 |
| Interaction | RBBP4 interactions | FNBP1 ASXL1 C9orf78 KMT2E JARID2 FZR1 FBXW8 TNRC18 DHFR2 SHPRH KDM2B RPA4 KPNA2 PHF12 CHAF1A ZFPM2 PPP2R2A DCD HNRNPUL2 MYBL2 | 6.89e-05 | 573 | 263 | 20 | int:RBBP4 |
| Interaction | IFI6 interactions | 7.13e-05 | 54 | 263 | 6 | int:IFI6 | |
| Interaction | SAA1 interactions | 7.13e-05 | 54 | 263 | 6 | int:SAA1 | |
| Interaction | BAG2 interactions | PI4K2B ASXL1 GAPVD1 SLK PIWIL1 CEP170 FZR1 SUPT6H MLF1 TACC3 WNK3 NCOA2 DNAJC13 PHF12 BRD3 PPP2R2B LATS2 DOCK7 PRKCG ELK1 PALLD | 7.27e-05 | 622 | 263 | 21 | int:BAG2 |
| Interaction | MORF4L2 interactions | 7.45e-05 | 168 | 263 | 10 | int:MORF4L2 | |
| Interaction | NUP43 interactions | DCAF1 JADE3 ZC3H13 AHDC1 NSD3 BRCA2 SUPT6H MKI67 NIPBL EP400 PHF12 PPHLN1 CCT2 NUP214 POM121C ZZZ3 RBMX2 ANKRD11 ZNF512 SLX4 MYBL2 | 7.78e-05 | 625 | 263 | 21 | int:NUP43 |
| Interaction | KCNA3 interactions | CHL1 GAPVD1 RPS9 CHD2 CEP170 CGN PDS5A PRRC2A MPP7 KPNA2 NCOA2 AFF2 CANX MAGI3 CCT2 NUP214 ERLIN1 FAM83B PHF3 EIF4B DOCK7 RP1 RIMS1 ATP1A1 PALLD HCLS1 | 7.87e-05 | 871 | 263 | 26 | int:KCNA3 |
| Interaction | SIRT6 interactions | PI4K2B GAPVD1 PATZ1 CEP170 UBE3A SUPT6H MKI67 PDS5A KPNA2 EP400 TUT7 LMTK2 NUP214 POM121C DHX30 PCF11 CELSR2 HNRNPUL2 PHF3 PALLD SLX4 | 8.32e-05 | 628 | 263 | 21 | int:SIRT6 |
| Interaction | CEBPA interactions | FNBP1 EPC2 ASXL1 C9orf78 RPS9 AHDC1 CEP170 TLK1 TNRC18 UBE3A ZBTB21 MKI67 PDS5A ZNF770 PRRC2A NIPBL NCOA2 EP400 EIF4H POLDIP3 PHF12 DIDO1 SPAG7 CCT2 PCF11 DCD HNRNPUL2 SF3B6 EIF4B GZMB ATP1A1 HNRNPR MYBL2 | 8.57e-05 | 1245 | 263 | 33 | int:CEBPA |
| Interaction | ANKRD50 interactions | 8.64e-05 | 108 | 263 | 8 | int:ANKRD50 | |
| Interaction | DDX54 interactions | RPS9 SSR1 FZR1 SUPV3L1 MKI67 PJA1 PRRC2A NOP16 NEIL1 CANX REST LYAR CBX6 ZNF512 SLX4 | 8.88e-05 | 362 | 263 | 15 | int:DDX54 |
| Interaction | H3-4 interactions | DCAF1 JADE3 AHDC1 REXO1 NSD3 SVIL NCOA2 HIRIP3 MRPS18B PHF12 CHAF1A DIDO1 CBX6 PHF3 OTUD6B HNRNPR NCKAP1L | 8.96e-05 | 448 | 263 | 17 | int:H3-4 |
| Interaction | TOP3B interactions | PDE4A PCNX3 KIAA0319L OBSCN AHDC1 REXO1 NSD3 FZR1 TLK1 TNRC18 TULP4 ZNRF3 SVIL PRRC2A PLK3 SEMA3F PITPNM2 EP400 KALRN POLDIP3 PHF12 LMTK2 TRMT1 NUP214 LYAR POM121C MADD DHX30 LATS2 CELSR2 MAP1S ZNF341 SSU72 RBMX2 MARK4 ANKRD11 MYBL2 | 9.03e-05 | 1470 | 263 | 37 | int:TOP3B |
| Interaction | BRCA1 interactions | GAPVD1 RPS9 OBSCN GATA3 CEP170 BRCA2 UBE3A SUPT6H MKI67 SLX4IP PDS5A TACC3 ALDH5A1 NIPBL RPA4 KPNA2 NCOA2 UBR2 PHF12 CHAF1A SMC6 PPHLN1 CCT2 NUP214 USP37 ERLIN1 PPP2R5C ZZZ3 HNRNPUL2 ELK1 PALLD SLX4 HNRNPR | 9.11e-05 | 1249 | 263 | 33 | int:BRCA1 |
| Interaction | NPM1 interactions | ASXL1 JADE3 RPS9 CCNO NEB SYNGAP1 FZR1 BRCA2 CLK1 EIF2B4 ZBTB21 MKI67 ZNF770 PRRC2A RPA4 DNAJC13 FYTTD1 NOP16 MRPS18B CHAF1A DIDO1 CCT2 BRD3 TUT1 REST LYAR DHX30 RBMX2 RP1 ZNF512 SLX4 HNRNPR | 1.00e-04 | 1201 | 263 | 32 | int:NPM1 |
| Interaction | H2AX interactions | TSSK6 RPS9 NEB STK4 FZR1 TNRC18 BRCA2 SUPT6H MKI67 KDM2B NIPBL HIRIP3 NEIL1 MRPS18B CHAF1A BRD3 DHX30 HNRNPUL2 HCLS1 HNRNPR | 1.10e-04 | 593 | 263 | 20 | int:H2AX |
| Interaction | CHEK2 interactions | NSD3 FZR1 BRCA2 SVIL MKI67 RPA4 PLK3 KPNA2 PPP2R2A PPP2R2B PPP2R5C LATS2 | 1.16e-04 | 250 | 263 | 12 | int:CHEK2 |
| Interaction | HNRNPA1 interactions | ASXL1 SLK RBM12B ZC3H13 RPS9 NEB FZR1 MRPL16 CLK1 SUPV3L1 MKI67 PRRC2A RPA4 UBR2 MRPS18B POLDIP3 CANX PPHLN1 DHX30 PCF11 DCD HNRNPUL2 PHF3 SF3B6 EIF4B SLX4 HNRNPR | 1.18e-04 | 945 | 263 | 27 | int:HNRNPA1 |
| Interaction | H3-3A interactions | DCAF1 FNBP1 C9orf78 CHD2 NSD3 ZBTB21 MKI67 SHPRH KDM2B PDS5A ZNF770 NIPBL HIRIP3 CHAF1A SMC6 DIDO1 BRD3 LYAR CBX6 PHF3 PHACTR3 ZNF512 MYBL2 | 1.37e-04 | 749 | 263 | 23 | int:H3-3A |
| Interaction | EED interactions | CHL1 DCAF1 EPC2 ASXL1 GAPVD1 RBM12B ZC3H13 RPS9 OBSCN CHD2 B4GALT1 STK4 JARID2 SUPT6H SVIL CGN SHPRH KDM2B PDS5A PJA1 KIF17 NIPBL KPNA2 FYTTD1 EP400 DIDO1 PPHLN1 CCT2 NUP214 PPP2R2A PPP2R5C HNRNPUL2 SF3B6 ATP1A1 HNRNPR MYBL2 | 1.39e-04 | 1445 | 263 | 36 | int:EED |
| Interaction | RPL18 interactions | CBLL1 DCAF1 PATZ1 RPS9 FZR1 MRPL16 MKI67 ZNF770 RPA4 REST LYAR DHX30 HNRNPUL2 OTUD6B EIF4B AUTS2 ZNF512 SLX4 | 1.46e-04 | 512 | 263 | 18 | int:RPL18 |
| Interaction | TMSB4Y interactions | 1.46e-04 | 39 | 263 | 5 | int:TMSB4Y | |
| Interaction | CLK3 interactions | ZC3H13 CLK1 KPNA2 HIRIP3 NEIL1 MRPS18B POLDIP3 PPHLN1 LYAR HNRNPUL2 HNRNPR | 1.56e-04 | 220 | 263 | 11 | int:CLK3 |
| Interaction | MORF4L1 interactions | EPC2 FZR1 BRCA2 KPNA2 EP400 FAM13C PHF12 SPTLC1 BRD3 AKR1C3 HNRNPR | 1.63e-04 | 221 | 263 | 11 | int:MORF4L1 |
| Interaction | NKX2-6 interactions | 1.70e-04 | 2 | 263 | 2 | int:NKX2-6 | |
| Interaction | AURKB interactions | NPIPB15 RBM12B RPS9 CEP170 EVI5 STK4 FZR1 TLK1 BRCA2 MRPL16 MKI67 DNAJC13 CCT2 NUP214 LYAR USP37 DHX30 PPP2R2A LATS2 MAP1S DOCK7 ATP1A1 HNRNPR | 1.72e-04 | 761 | 263 | 23 | int:AURKB |
| Interaction | PEA15 interactions | 1.77e-04 | 90 | 263 | 7 | int:PEA15 | |
| Interaction | CCT5 interactions | CBLL1 PI4K2B ASXL1 TSSK6 RPS9 SSR1 JARID2 FZR1 FBXW8 AGO4 RPA4 DNAJC13 CCT2 PPP2R2A PPP2R2B EIF4B MAPK4 SLX4 | 1.98e-04 | 525 | 263 | 18 | int:CCT5 |
| Interaction | MED23 interactions | EPC2 C9orf78 ZC3H13 SSR1 MED26 NIPBL NCOA2 EP400 BRD3 PNISR DOCK7 SLX4 | 2.07e-04 | 266 | 263 | 12 | int:MED23 |
| Interaction | CHD8 interactions | 2.33e-04 | 193 | 263 | 10 | int:CHD8 | |
| Interaction | PARP1 interactions | GAPVD1 C9orf78 NSD3 CEP170 FZR1 BRCA2 SUPT6H STARD9 SVIL ZBTB21 MKI67 SHPRH KDM2B SLX4IP PIP5K1A PDS5A NIPBL RPA4 EP400 CANX LMTK2 DIDO1 BRD3 REST LYAR PPP2R2A PHF3 GZMB DOCK7 ZNF512 SLX4 HNRNPR MYBL2 | 2.40e-04 | 1316 | 263 | 33 | int:PARP1 |
| Interaction | SET interactions | GAB2 FZR1 UBE3A SUPT6H FYTTD1 HIRIP3 NOP16 CHAF1A CCT2 BRD3 NUP214 CBX6 SETBP1 | 2.40e-04 | 311 | 263 | 13 | int:SET |
| Interaction | TCEAL7 interactions | 2.45e-04 | 24 | 263 | 4 | int:TCEAL7 | |
| Interaction | LINC02910 interactions | 2.47e-04 | 95 | 263 | 7 | int:LINC02910 | |
| Interaction | KLF5 interactions | LDB1 KDM2B PRRC2A NIPBL NCOA2 EP400 NOP16 MRPS18B POLDIP3 PHF12 | 2.53e-04 | 195 | 263 | 10 | int:KLF5 |
| Interaction | PPP1CC interactions | CBLL1 SPAG1 RBM12B ZC3H13 RPS9 SUPT6H STARD9 SVIL MKI67 PPP1R3F KPNA2 MRPS18B PHF12 LMTK2 PPHLN1 CCT2 FAM83B DHX30 MISP PPP2R5C PHACTR3 SLX4 | 2.88e-04 | 738 | 263 | 22 | int:PPP1CC |
| Interaction | CCDC137 interactions | 3.10e-04 | 200 | 263 | 10 | int:CCDC137 | |
| Interaction | CIT interactions | NES RBM12B ZC3H13 RPS9 CHD2 CEP170 SUPT6H SVIL MKI67 PDS5A ECI2 PRRC2A NIPBL KPNA2 EP400 NOP16 KALRN POLDIP3 CHAF1A CANX MAGI3 DIDO1 CCT2 BRD3 LYAR ERLIN1 DHX30 MISP LATS2 CELSR2 DCD HNRNPUL2 RP9 ATP1A1 HNRNPR | 3.15e-04 | 1450 | 263 | 35 | int:CIT |
| Interaction | NCL interactions | DCAF1 ASXL1 RPS9 SYNGAP1 CEP170 FZR1 BRCA2 CLK1 SUPT6H RPA4 FYTTD1 NEIL1 MRPS18B POLDIP3 DIDO1 REST LYAR DHX30 CBX6 OTUD6B EIF4B SLX4 HNRNPR | 3.39e-04 | 798 | 263 | 23 | int:NCL |
| Interaction | GATA4 interactions | SP100 SLK PATZ1 JARID2 ZBTB21 KPNA2 FYTTD1 EP400 POLDIP3 CANX PPHLN1 ZFPM2 HNRNPUL2 ATP1A1 HNRNPR | 3.51e-04 | 411 | 263 | 15 | int:GATA4 |
| Interaction | COIL interactions | JADE3 NSD3 SYNGAP1 SUPT6H ZBTB21 MKI67 KDM2B PDS5A NIPBL KPNA2 KALRN DCP2 BRD3 DHX30 ANKRD11 ATP1A1 ZNF512 MYBL2 | 3.63e-04 | 552 | 263 | 18 | int:COIL |
| Interaction | DCAF7 interactions | SP100 GATA3 CEP170 FZR1 SVIL NIPBL CCT2 LATS2 DCD CBX6 MARK4 DOCK7 AUTS2 PAX7 | 3.64e-04 | 368 | 263 | 14 | int:DCAF7 |
| Interaction | RNF4 interactions | CBLL1 DCAF1 SP100 GAPVD1 PATZ1 GATA3 CHD2 KMT2E B4GALT1 SYNGAP1 CLK1 MKI67 PDS5A RMND1 KPNA2 DNAJC13 CANX SMC6 SPTLC1 GOSR2 ERLIN1 ATF6 MISP PPP2R5C ZZZ3 NKD2 DCD PHF3 DOCK7 AUTS2 ATP1A1 ZNF512 SLX4 HNRNPR | 4.03e-04 | 1412 | 263 | 34 | int:RNF4 |
| Interaction | CCDC8 interactions | GAPVD1 CEP170 FZR1 FBXW8 SVIL CGN ZBTB21 MKI67 NIPBL KPNA2 CACNA2D1 EP400 POLDIP3 CANX CCT2 FAM83B DHX30 DOCK7 ATP1A1 HNRNPR | 4.10e-04 | 656 | 263 | 20 | int:CCDC8 |
| Interaction | SUMO1 interactions | SP100 C9orf78 UBE3A MKI67 PRRC2A RPA4 NCOA2 CHAF1A CANX BRD3 RP9 SLX4 | 4.13e-04 | 287 | 263 | 12 | int:SUMO1 |
| Interaction | MAGEA11 interactions | 4.23e-04 | 136 | 263 | 8 | int:MAGEA11 | |
| Interaction | EGR2 interactions | 4.25e-04 | 171 | 263 | 9 | int:EGR2 | |
| Interaction | HDAC2 interactions | DCAF1 MBTPS1 C9orf78 GATA3 JARID2 FZR1 BRCA2 EIF2B4 MKI67 KPNA2 DNAJC13 EP400 PHF12 CHAF1A CANX REST USP37 ZFPM2 PPP2R2A LATS2 DCD ATP1A1 HNRNPR MYBL2 | 4.36e-04 | 865 | 263 | 24 | int:HDAC2 |
| Interaction | KPNA3 interactions | KMT2E FZR1 KPNA2 CUX2 POLDIP3 CANX BRD3 NUP214 POM121C ANKRD11 SLX4 | 4.37e-04 | 248 | 263 | 11 | int:KPNA3 |
| Interaction | NR3C1 interactions | FNBP1 GAPVD1 WDR64 CHD2 SSR1 NEB KLHL3 UBE3A SVIL KDM2B NIPBL KPNA2 NCOA2 PHF12 CANX NUP214 POM121C USP8 PPP2R2B DCD PHACTR3 ATP1A1 DNAAF1 ZNF512 HNRNPR MYBL2 | 4.52e-04 | 974 | 263 | 26 | int:NR3C1 |
| Interaction | RPL4 interactions | DCAF1 PATZ1 RPS9 SSR1 AHDC1 FZR1 DHFR2 MKI67 ZNF770 PRRC2A RPA4 NOP16 TUT7 BRD3 REST LYAR DHX30 OTUD6B SF3B6 ANKRD11 ZNF512 SLX4 | 4.61e-04 | 764 | 263 | 22 | int:RPL4 |
| Interaction | MTA3 interactions | 4.62e-04 | 173 | 263 | 9 | int:MTA3 | |
| Interaction | WDR46 interactions | 4.62e-04 | 173 | 263 | 9 | int:WDR46 | |
| Interaction | WWTR1 interactions | GAPVD1 SLK CEP170 CGN OSBPL11 TACC3 PRRC2A KPNA2 NCOA2 EP400 DIDO1 ZZZ3 LATS2 PHF3 DOCK7 | 4.62e-04 | 422 | 263 | 15 | int:WWTR1 |
| Interaction | PNMA2 interactions | SP100 CEP170 PRRC2A FYTTD1 POM121C FAM83B MISP LATS2 MARK4 SLX4 MYBL2 | 4.83e-04 | 251 | 263 | 11 | int:PNMA2 |
| Cytoband | 8p23.1 | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 3.71e-09 | 154 | 283 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 2.72e-07 | 234 | 283 | 11 | chr8p23 |
| Cytoband | 19q13.4 | 1.33e-04 | 79 | 283 | 5 | 19q13.4 | |
| GeneFamily | PHD finger proteins | 1.04e-08 | 90 | 167 | 10 | 88 | |
| GeneFamily | RNA binding motif containing | 1.66e-04 | 213 | 167 | 9 | 725 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.25e-04 | 15 | 167 | 3 | 696 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.45e-03 | 53 | 167 | 4 | 532 | |
| GeneFamily | Non-canonical poly(A) polymerases | 1.73e-03 | 7 | 167 | 2 | 1318 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.73e-03 | 7 | 167 | 2 | 1208 | |
| GeneFamily | Argonaute/PIWI family | 2.29e-03 | 8 | 167 | 2 | 408 | |
| GeneFamily | Paired boxes | 2.93e-03 | 9 | 167 | 2 | 675 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ASXL1 GAPVD1 NPIPB5 AHDC1 CEP170 JARID2 TLK1 MKI67 DIDO1 PNISR PCF11 ZZZ3 PHF3 AKR1C3 AUTS2 | 5.68e-07 | 300 | 269 | 15 | M8702 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FNBP1 GAPVD1 SLK PHF20 C9orf78 GATA3 CHD2 KMT2E STK4 JARID2 TLK1 UBE3A CLK1 PDS5A VAV3 NIPBL UBR2 FYTTD1 TANK EP400 DCP2 SESN3 PPHLN1 REST PNISR PCF11 PPP2R2B PPP2R5C SYTL3 PHF3 EIF4B GZMB ANKRD11 AUTS2 FAM53B HCLS1 NCKAP1L | 6.29e-07 | 1492 | 269 | 37 | M40023 |
| Coexpression | GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | PDE3B RPS9 REXO1 JARID2 KLHL3 EIF2B4 PJA1 PHF12 SESN3 TUT1 EIF4B | 2.11e-06 | 175 | 269 | 11 | M8908 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | MYF6 SP100 NPIPB15 OBSCN STK4 JARID2 SUPV3L1 MKI67 PDS5A LILRB4 UBR2 DNAJC13 TANK AFF2 EP400 EIF4H NOP16 CHAF1A DCP2 DIDO1 NUP214 ADAM22 PCF11 PPP2R5C ZZZ3 PHF3 EIF4B FAM53B RIMS1 NXPH2 HCLS1 HNRNPR MYBL2 NCKAP1L | 2.70e-06 | 1394 | 269 | 34 | M9585 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 SP100 GAPVD1 SLK PHF20 AHDC1 CEP170 EVI5 JARID2 TLK1 BRCA2 UBE3A PIP5K1A PDS5A NIPBL NCOA2 UBR2 DNAJC13 TANK PNISR PCF11 PPP2R2A PPP2R5C ZZZ3 PHF3 | 3.01e-06 | 856 | 269 | 25 | M4500 |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | MBTPS1 LDB1 SUPT6H PITPNM2 TRMT1 DIDO1 REST GOSR2 DHX30 LATS2 CBX6 | 7.61e-06 | 200 | 269 | 11 | M8278 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | CELF4 PATZ1 UBE3A CLK1 SUPT6H MKI67 PDS5A PJA1 AFF2 POLDIP3 CANX LMTK2 CCT2 BRD3 LYAR MISP NKD2 CELSR2 MYBL2 | 2.01e-05 | 610 | 269 | 19 | M3854 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | GAPVD1 SLK NPIPB5 CEP170 EVI5 JARID2 TLK1 UBE3A PDS5A UBR2 DNAJC13 PNISR PPP2R2A PPP2R5C ZZZ3 PHF3 | 2.89e-05 | 466 | 269 | 16 | M13522 |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN | 3.30e-05 | 193 | 269 | 10 | M6903 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 4.46e-05 | 200 | 269 | 10 | M8954 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | CELF4 PATZ1 UBE3A CLK1 SUPT6H MKI67 PDS5A PJA1 AFF2 POLDIP3 CANX CCT2 BRD3 LYAR POM121C MISP NKD2 CELSR2 MYBL2 | 4.75e-05 | 650 | 269 | 19 | MM1042 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | ASXL1 SP100 GATA3 CHD2 NSD3 EVI5 JARID2 TLK1 EXOC6B PPP1R3F ECI2 NIPBL PPP2R5C LATS2 ANKRD11 RP9 | 6.36e-05 | 498 | 269 | 16 | M1741 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | ASXL1 SP100 GATA3 CHD2 NSD3 EVI5 JARID2 TLK1 EXOC6B PPP1R3F ECI2 NIPBL PPP2R5C LATS2 ANKRD11 RP9 | 7.84e-05 | 507 | 269 | 16 | MM1030 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | GAPVD1 PATZ1 ZC3H13 CHD2 NSD3 TLK1 TULP4 UBE3A PIP5K1A DNAJC13 DIDO1 PNISR COA8 ANKRD11 ELK1 | 2.00e-06 | 275 | 264 | 15 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | GAPVD1 PHF20 PATZ1 ZC3H13 CHD2 NSD3 TNRC18 PIP5K1A MPP7 DNAJC13 DIDO1 PNISR COA8 ANKRD11 | 4.89e-06 | 259 | 264 | 14 | gudmap_developingGonad_e12.5_epididymis_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CBLL1 EPC2 SLK CELF4 PHF20 CHD2 CEP170 STK4 CLK1 SUPT6H MKI67 VAV3 WNK3 MPP7 FAM13C PHF12 CANX DIDO1 PPHLN1 PNISR CELSR2 ATP1A3 | 5.84e-06 | 595 | 264 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | GAPVD1 PHF20 PATZ1 ZC3H13 CHD2 NSD3 TNRC18 UBE3A STARD9 DIDO1 PNISR COA8 ANKRD11 ELK1 | 1.39e-05 | 284 | 264 | 14 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DCAF1 EPC2 NES SP100 PDE3B PHF20 ZC3H13 GATA3 TULP1 STK4 DUOX1 BRCA2 ZNRF3 CGN MKI67 MLF1 ADAMTS18 ALDH5A1 NIPBL PLK3 WNK3 NCOA2 CUX2 AFF2 HIRIP3 SMC6 RASGEF1A PPHLN1 LYAR MADD DHX30 CELSR2 SYTL3 SETBP1 DOCK7 MAPK4 MYBL2 | 1.43e-05 | 1414 | 264 | 37 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CBLL1 DCAF1 EPC2 NES PDE4A JADE3 ZC3H13 JARID2 NLGN3 TLK1 BRCA2 MKI67 KDM2B ALDH5A1 NIPBL WNK3 NCOA2 CUX2 AFF2 HIRIP3 PHF12 CHAF1A SMC6 PPHLN1 USP37 ATP10A DHX30 CELSR2 PHF3 RBMX2 SETBP1 DOCK7 AUTS2 RIMS1 MAPK4 MYBL2 | 1.73e-05 | 1370 | 264 | 36 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | GAPVD1 PATZ1 ZC3H13 CHD2 NSD3 UBE3A PIP5K1A DNAJC13 DIDO1 PNISR COA8 ANKRD11 | 3.31e-05 | 230 | 264 | 12 | gudmap_developingGonad_e16.5_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | PATZ1 ZC3H13 CHD2 NSD3 TNRC18 UBE3A DNAJC13 PNISR COA8 ANKRD11 | 3.67e-05 | 162 | 264 | 10 | gudmap_developingGonad_e16.5_epididymis_500_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CHD2 BRCA2 MKI67 PDS5A NIPBL NCOA2 CACNA2D1 HIRIP3 CANX SMC6 LYAR PNISR SETBP1 RP9 | 3.80e-05 | 311 | 264 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CBLL1 EPC2 SLK CHD2 CEP170 BRCA2 CLK1 SUPT6H MKI67 OSBPL11 NIPBL MPP7 CACNA2D1 PHF12 SMC6 DIDO1 PPHLN1 REST PNISR ADAM22 ZZZ3 | 4.31e-05 | 629 | 264 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CHD2 UPF3A SYNGAP1 STK4 R3HCC1L BRCA2 MKI67 PDS5A NIPBL MPP7 NCOA2 CACNA2D1 HIRIP3 CANX TUT7 SMC6 SESN3 LYAR PNISR PPP2R5C SETBP1 ZFYVE19 RP9 SLX4 GABBR1 | 4.47e-05 | 831 | 264 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | PHF20 PATZ1 ZC3H13 CHD2 NSD3 TNRC18 UBE3A STARD9 MPP7 DNAJC13 PNISR COA8 ANKRD11 | 5.44e-05 | 281 | 264 | 13 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | GAPVD1 PATZ1 ZC3H13 CHD2 TNRC18 UBE3A STARD9 MPP7 DNAJC13 PNISR COA8 ANKRD11 | 7.13e-05 | 249 | 264 | 12 | gudmap_developingGonad_P2_epididymis_1000_k3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CBLL1 DCAF1 EPC2 PDE3B PHF20 ZC3H13 EVI5 STK4 JARID2 BRCA2 SUPV3L1 MKI67 PDS5A ZNF770 ALDH5A1 NIPBL WNK3 HIRIP3 CANX SMC6 PPHLN1 LYAR PNISR DHX30 PHF3 RBMX2 SETBP1 DOCK7 AUTS2 DIXDC1 NHEJ1 MYBL2 | 9.60e-05 | 1257 | 264 | 32 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CBLL1 DCAF1 EPC2 NES PDE3B PHF20 ZC3H13 EVI5 STK4 JARID2 BRCA2 SUPV3L1 MKI67 PDS5A ZNF770 ALDH5A1 NIPBL WNK3 AFF2 HIRIP3 CANX SMC6 PPHLN1 LYAR PNISR DHX30 PHF3 RBMX2 SETBP1 DOCK7 AUTS2 DIXDC1 MAPK4 NHEJ1 MYBL2 | 1.43e-04 | 1459 | 264 | 35 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | DCAF1 EPC2 PDE3B PHF20 ZC3H13 TULP1 STK4 BRCA2 ZNRF3 MKI67 MLF1 ADAMTS18 ALDH5A1 NIPBL WNK3 NCOA2 CUX2 HIRIP3 SMC6 PPHLN1 LYAR MADD DHX30 CELSR2 SETBP1 DOCK7 MAPK4 MYBL2 | 1.47e-04 | 1060 | 264 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | GAPVD1 PATZ1 ZC3H13 CHD2 NSD3 UBE3A PIP5K1A DNAJC13 DIDO1 PNISR COA8 ANKRD11 | 1.94e-04 | 277 | 264 | 12 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | EPC2 PDE3B SLK ZC3H13 CHD2 CEP170 CLK1 SUPT6H MKI67 OSBPL11 ZNF770 VAV3 DIDO1 PPHLN1 REST LYAR PNISR ZZZ3 | 2.64e-04 | 564 | 264 | 18 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SP100 PDE3B NPIPB4 CHD2 NPIPB5 CLK1 UBR2 PNISR PPP2R5C SYTL3 PHF3 ANKRD11 | 3.95e-09 | 199 | 272 | 12 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | CDH23 NLGN3 MED26 KIF17 LILRB4 CUX2 ZAN CHAF1A NKD2 GZMB AKR1C3 MYBL2 | 4.94e-09 | 203 | 272 | 12 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | GATA3 B4GALT1 VAV3 KIR3DL2 LYAR PPP2R2B SYTL3 SETBP1 GZMB AUTS2 FAM53B | 4.12e-08 | 198 | 272 | 11 | faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | ZC3H13 CEP170 EVI5 TLK1 UBE3A NIPBL KPNA2 CCT2 REST ANKRD11 AKR1C3 | 4.12e-08 | 198 | 272 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | SP100 ZC3H13 KMT2E NSD3 NIPBL SMC6 SESN3 REST PHF3 ANKRD11 PALLD | 4.33e-08 | 199 | 272 | 11 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | MTSS1 VAV3 KIR3DL2 MADD PPP2R2B PPP2R5C SYTL3 GZMB AUTS2 HSH2D | 2.56e-07 | 188 | 272 | 10 | c9a227c8e71b69929d43e9afb8306a95c8163778 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | PDE4A B4GALT1 VAV3 KIR3DL2 LYAR PPP2R2B SYTL3 SETBP1 GZMB FAM53B | 3.43e-07 | 194 | 272 | 10 | 52e09b14159b609af00264a8f38accf37ba8f464 |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | SPAG1 PDE4A GATA3 AHDC1 B4GALT1 KDM2B MADD SYTL3 ANKRD11 HSH2D | 3.59e-07 | 195 | 272 | 10 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | FNBP1 RPS9 KMT2E SVIL CUX2 PNISR PPP2R2B CELSR2 SETBP1 AUTS2 | 3.77e-07 | 196 | 272 | 10 | 38da0751941adca650fe9b383d9f343153978eb5 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | FNBP1 RPS9 KMT2E SVIL CUX2 PNISR PPP2R2B CELSR2 SETBP1 AUTS2 | 3.77e-07 | 196 | 272 | 10 | 721650a08d260faf530dbd52d4e9275d27f3bac2 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | PDE4A B4GALT1 VAV3 MADD SYTL3 GZMB AKR1C3 AUTS2 HSH2D FAM53B | 3.77e-07 | 196 | 272 | 10 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | PDE4A B4GALT1 VAV3 MADD SYTL3 GZMB AKR1C3 AUTS2 HSH2D FAM53B | 3.77e-07 | 196 | 272 | 10 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.95e-07 | 197 | 272 | 10 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 4.33e-07 | 199 | 272 | 10 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 4.33e-07 | 199 | 272 | 10 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.33e-07 | 199 | 272 | 10 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.53e-07 | 200 | 272 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-07 | 162 | 272 | 9 | 74cd0de957fdbe527656befd61f67d6814ce9e98 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-06 | 173 | 272 | 9 | 0451450605521fecb27a958628870d268adfb023 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 173 | 272 | 9 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-06 | 174 | 272 | 9 | 4120656e6d6cf5435a248326b5fdbdc7b22137af | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-06 | 176 | 272 | 9 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-06 | 176 | 272 | 9 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-06 | 184 | 272 | 9 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.15e-06 | 185 | 272 | 9 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 185 | 272 | 9 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-06 | 187 | 272 | 9 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 187 | 272 | 9 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-06 | 188 | 272 | 9 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 2.56e-06 | 189 | 272 | 9 | ee4c1d930534788a7759d92dc8ff9c62e6ee2301 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.56e-06 | 189 | 272 | 9 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.56e-06 | 189 | 272 | 9 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 2.68e-06 | 190 | 272 | 9 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 2.68e-06 | 190 | 272 | 9 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.68e-06 | 190 | 272 | 9 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-06 | 191 | 272 | 9 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.91e-06 | 192 | 272 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 2.91e-06 | 192 | 272 | 9 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 3.04e-06 | 193 | 272 | 9 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.04e-06 | 193 | 272 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 3.04e-06 | 193 | 272 | 9 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 3.04e-06 | 193 | 272 | 9 | 35c902a983d7f1156a74fe68ee366609029833b3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.17e-06 | 194 | 272 | 9 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 3.17e-06 | 194 | 272 | 9 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | 343B-Lymphocytic-NK_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-06 | 195 | 272 | 9 | 33a460624a65ba033452c74d143089e0bfac8f3d | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 3.31e-06 | 195 | 272 | 9 | 789149fb52d9d16393e1649358515add60d37f2d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 3.31e-06 | 195 | 272 | 9 | e756733cf48768bf40058d6cf9039e52f7563133 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lung / Location, Cell class and cell subclass | 3.60e-06 | 197 | 272 | 9 | de26ca046038e34790cece24529a05d491e6f8ef | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.75e-06 | 198 | 272 | 9 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.90e-06 | 199 | 272 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | severe-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.07e-06 | 200 | 272 | 9 | 2e67068b98696c313b815a2f0c98643f892e8bc0 | |
| ToppCell | COVID-19_Mild-NK|COVID-19_Mild / Disease condition and Cell class | 4.07e-06 | 200 | 272 | 9 | b586b0f1127293c2f8529be16b24229359041da2 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.24e-06 | 151 | 272 | 8 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.51e-06 | 166 | 272 | 8 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 8.90e-06 | 167 | 272 | 8 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 9.29e-06 | 168 | 272 | 8 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.29e-06 | 168 | 272 | 8 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 1.01e-05 | 170 | 272 | 8 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 1.06e-05 | 171 | 272 | 8 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | ILEUM-inflamed-(1)_T_(gd)|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.15e-05 | 173 | 272 | 8 | 85c3e227c81c6ab70148639381389fba3ac5e088 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.25e-05 | 175 | 272 | 8 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | 11.5-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 1.25e-05 | 175 | 272 | 8 | d8ca8fbe5309dab293c335b32f1b138edfdd0b07 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 175 | 272 | 8 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 175 | 272 | 8 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 176 | 272 | 8 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 1.36e-05 | 177 | 272 | 8 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-05 | 180 | 272 | 8 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 181 | 272 | 8 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | 15-Trachea-Immune-Hematopoietic,_B_Cells|Trachea / Age, Tissue, Lineage and Cell class | 1.66e-05 | 182 | 272 | 8 | 1424d990598d37b22fa44df032be97c1cd1363d1 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 182 | 272 | 8 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 1.66e-05 | 182 | 272 | 8 | 6e35892fa959ee31591850ded8f1088195ddeb01 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 1.73e-05 | 183 | 272 | 8 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 186 | 272 | 8 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.94e-05 | 186 | 272 | 8 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.94e-05 | 186 | 272 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.10e-05 | 188 | 272 | 8 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-05 | 188 | 272 | 8 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-05 | 188 | 272 | 8 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-05 | 188 | 272 | 8 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 2.10e-05 | 188 | 272 | 8 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.18e-05 | 189 | 272 | 8 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 2.18e-05 | 189 | 272 | 8 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | metastatic_Brain-T/NK_cells-NK|metastatic_Brain / Location, Cell class and cell subclass | 2.26e-05 | 190 | 272 | 8 | 50e937ba0600e1ac6215f056bb545dc1e8b28a76 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-05 | 190 | 272 | 8 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 190 | 272 | 8 | 81e7d4f97b958b4ed14298a77104ef31a6ec6c91 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 190 | 272 | 8 | a1b19028c36d192352bc8a7f187790f4b56cfe17 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 190 | 272 | 8 | 423b54c6d48d6981a9522043252239303dccaf04 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-05 | 191 | 272 | 8 | f7a42a9d7493ea25cd8bd297c22e49e4bad7f0a4 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-05 | 191 | 272 | 8 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | Control-Lymphoid-ILC_A|Control / Disease state, Lineage and Cell class | 2.35e-05 | 191 | 272 | 8 | 1ca73582dc3d28322b5ee841010067589d848acc | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-05 | 191 | 272 | 8 | 2b427741a58921e161101a282d1fe526cd9e760d | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 2.44e-05 | 192 | 272 | 8 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.44e-05 | 192 | 272 | 8 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.44e-05 | 192 | 272 | 8 | faead5875a54fe8f1848ae36008aae4c0f7cb1c7 | |
| ToppCell | proximal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.44e-05 | 192 | 272 | 8 | 86938c7d2bb1a7afb2b83828ca33dd137d366ec6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 2.44e-05 | 192 | 272 | 8 | 4d72b9264ed62e0c08cde4078061b348253f6989 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.44e-05 | 192 | 272 | 8 | e3be395a995dc8c0ebdae754057cfa59a270cae0 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-05 | 193 | 272 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 193 | 272 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 193 | 272 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| Drug | chlorpromazine hydrochloride; Down 200; 10uM; MCF7; HG-U133A | FNBP1 JADE3 CASKIN2 SUPT6H VAV3 ALDH5A1 NCOA2 SEMA3F EP400 ADAM22 ATF6 HNRNPUL2 | 3.32e-06 | 196 | 264 | 12 | 419_DN |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | RPS9 EVI5 FZR1 R3HCC1L CASKIN2 SVIL PLK3 NCOA2 DNAJC13 TUT1 REST DNAAF1 | 3.32e-06 | 196 | 264 | 12 | 4965_DN |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | MTSS1 TULP1 B4GALT1 FZR1 EXOC6B CACNA2D1 NUP214 PPP2R2B PHF3 DGKI ELK1 PAX7 | 3.69e-06 | 198 | 264 | 12 | 4096_UP |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; HL60; HT_HG-U133A | PATZ1 NSD3 AGO4 BRCA2 SVIL PRRC2A RPA4 POLDIP3 TUT1 CELSR2 MAP1S MARK4 | 3.69e-06 | 198 | 264 | 12 | 2398_DN |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | PHF20 UPF3A NEB NSD3 VAV3 PLK3 KALRN POLDIP3 REST CELSR2 MYO15A LYL1 | 3.69e-06 | 198 | 264 | 12 | 6352_UP |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | JARID2 TLK1 BRCA2 UBE3A OSBPL11 VAV3 NIPBL NCOA2 UBR2 TUT7 ZZZ3 | 9.64e-06 | 182 | 264 | 11 | 3887_DN |
| Drug | Antigens, Polyomavirus Transforming | ASXL1 CELF4 RPS9 SSR1 B4GALT1 STK4 TNRC18 PIP5K1A MPP7 NCOA2 CANX LMTK2 SPAG7 CCT2 BRD3 GOSR2 HABP4 RBMX2 DOCK7 ANKRD11 RP9 MYBL2 | 1.21e-05 | 668 | 264 | 22 | ctd:D000952 |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | SP100 PDE4A RPS9 R3HCC1L NIPBL NCOA2 TANK GOSR2 PNISR PPP2R5C PCIF1 | 1.84e-05 | 195 | 264 | 11 | 4961_DN |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | STK4 FZR1 LDB1 BRCA2 CASKIN2 MKI67 SPAG7 TUT1 HABP4 SETBP1 FAM53B | 1.84e-05 | 195 | 264 | 11 | 6614_DN |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 1.84e-05 | 195 | 264 | 11 | 2126_UP | |
| Drug | benserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | ASXL1 KIAA0319L LDB1 UBE3A MKI67 PDS5A NIPBL NOP16 DIDO1 HABP4 MISP | 1.93e-05 | 196 | 264 | 11 | 631_DN |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | PDE3B PHF20 MTSS1 NEB FZR1 SUPT6H CUX2 PPP2R2B PAX5 PAX7 JHY | 2.03e-05 | 197 | 264 | 11 | 5528_UP |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | NEB EVI5 FZR1 CASKIN2 SUPT6H SVIL SEMA3F HABP4 PPP2R2B SH3GLB1 MARK4 | 2.22e-05 | 199 | 264 | 11 | 5358_UP |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 7.92e-05 | 190 | 264 | 10 | 5080_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | SP100 KIAA0319L NSD3 B4GALT1 TLK1 BRCA2 CASKIN2 CANX ADAM22 HNRNPUL2 | 8.27e-05 | 191 | 264 | 10 | 3803_DN |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; HL60; HG-U133A | 8.64e-05 | 192 | 264 | 10 | 1580_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | PHF20 B4GALT1 R3HCC1L SVIL PLK3 TUT1 GOSR2 PNISR ADAM22 PHF3 | 8.64e-05 | 192 | 264 | 10 | 6054_DN |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 9.02e-05 | 193 | 264 | 10 | 4289_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | SP100 KIAA0319L SSR1 TLK1 PLK3 PPP2R2B HNRNPUL2 MARK4 ELK1 PAX5 | 9.02e-05 | 193 | 264 | 10 | 4406_DN |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A | SP100 GATA3 B4GALT1 LDB1 PLK3 SEMA3F TANK POLDIP3 PHF3 DNAAF1 | 9.02e-05 | 193 | 264 | 10 | 6699_DN |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | KIAA0319L AHDC1 NSD3 STK4 CASKIN2 EP400 HABP4 HNRNPUL2 PHF3 ELK1 | 9.41e-05 | 194 | 264 | 10 | 1060_UP |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 9.41e-05 | 194 | 264 | 10 | 4662_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; HL60; HT_HG-U133A | NES PDE4A ZC3H13 MTSS1 KLHL3 AFF2 POLDIP3 TUT1 ADAM22 PPP2R2B | 9.82e-05 | 195 | 264 | 10 | 2924_UP |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | KIAA0319L STK4 FZR1 LDB1 CASKIN2 SEMA3F REST PNISR PCIF1 JHY | 9.82e-05 | 195 | 264 | 10 | 2121_UP |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; PC3; HT_HG-U133A | PHF20 KIAA0319L CCNO CASKIN2 PRRC2A PLK3 SEMA3F TUT1 REST PNISR | 9.82e-05 | 195 | 264 | 10 | 2113_UP |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | PDE3B KIAA0319L CCNO STK4 SEMA3F LMTK2 MARK4 AUTS2 ELK1 PAX5 | 1.02e-04 | 196 | 264 | 10 | 4974_UP |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | SP100 PDE4A BRCA2 NIPBL POLDIP3 CHAF1A GOSR2 MISP HNRNPUL2 FAM53B | 1.02e-04 | 196 | 264 | 10 | 7265_DN |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; PC3; HG-U133A | 1.02e-04 | 196 | 264 | 10 | 1894_UP | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | PDE3B B4GALT1 STK4 FZR1 NCOA2 POLDIP3 TUT1 HABP4 HNRNPUL2 DNAAF1 | 1.02e-04 | 196 | 264 | 10 | 6899_DN |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | KIAA0319L CCNO B4GALT1 EVI5 FZR1 SUPT6H NCOA2 MAP1S HNRNPUL2 DIXDC1 | 1.02e-04 | 196 | 264 | 10 | 5261_DN |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.07e-04 | 197 | 264 | 10 | 2117_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 264 | 10 | 5643_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A | NEB NSD3 B4GALT1 CASKIN2 NCOA2 SEMA3F CHAF1A TUT1 MAP1S PAX5 | 1.07e-04 | 197 | 264 | 10 | 5360_UP |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; HL60; HT_HG-U133A | 1.07e-04 | 197 | 264 | 10 | 2341_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.07e-04 | 197 | 264 | 10 | 4017_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | PHF20 KIAA0319L NEB B4GALT1 KEL AFF2 PPP2R2B PHF3 AUTS2 DIXDC1 | 1.07e-04 | 197 | 264 | 10 | 2326_DN |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | FNBP1 PHF20 NSD3 FZR1 CASKIN2 NCOA2 AFF2 POLDIP3 ADAM22 MAP1S | 1.07e-04 | 197 | 264 | 10 | 7358_UP |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | PDE3B RPS9 KIAA0319L B4GALT1 STK4 CLK1 GOSR2 ELK1 PAX5 DNAAF1 | 1.07e-04 | 197 | 264 | 10 | 5576_DN |
| Drug | ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | NES UBE3A MKI67 OSBPL11 PDS5A NCOA2 SEMA3F PNISR PHF3 AKR1C3 | 1.07e-04 | 197 | 264 | 10 | 882_DN |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | PHF20 RPS9 NSD3 R3HCC1L NCOA2 SEMA3F REST GOSR2 ADAM22 ERLIN1 | 1.07e-04 | 197 | 264 | 10 | 6063_DN |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 197 | 264 | 10 | 3443_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 264 | 10 | 2060_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 264 | 10 | 4788_DN | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | CHL1 KIAA0319L KIF17 LILRB4 CUX2 ADAM29 TUT1 GOSR2 ADAM22 SETBP1 | 1.11e-04 | 198 | 264 | 10 | 6395_UP |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 264 | 10 | 4729_DN | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A | UPF3A STK4 SVIL TANK HIRIP3 CHAF1A PNISR HNRNPUL2 AKR1C3 FAM53B | 1.11e-04 | 198 | 264 | 10 | 6225_DN |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 264 | 10 | 3270_UP | |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | PDE4A UPF3A SUPT6H ALDH5A1 NIPBL R3HCC1 ADAM22 DHX30 PHF3 MARK4 | 1.11e-04 | 198 | 264 | 10 | 2877_DN |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; HL60; HT_HG-U133A | SLK ZNF268 STK4 ECI2 LILRB4 SEMA3F SPTLC1 HNRNPUL2 PHF3 MARK4 | 1.16e-04 | 199 | 264 | 10 | 1281_DN |
| Drug | Luteolin [491-70-3]; Up 200; 14uM; PC3; HT_HG-U133A | DCAF1 PDE3B ZNF268 CCNO KIF17 NEIL1 ELK1 RIMS1 MYO15A NCKAP1L | 1.16e-04 | 199 | 264 | 10 | 6658_UP |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A | 1.16e-04 | 199 | 264 | 10 | 1751_DN | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 264 | 10 | 1519_DN | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A | PDE3B PDE4A KIAA0319L FZR1 SUPT6H PLK3 LMTK2 TUT1 HABP4 PAX5 | 1.21e-04 | 200 | 264 | 10 | 3385_DN |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A | 1.21e-04 | 200 | 264 | 10 | 2116_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; PC3; HT_HG-U133A | 1.21e-04 | 200 | 264 | 10 | 7268_DN | |
| Disease | Neurodevelopmental Disorders | 1.26e-06 | 93 | 249 | 8 | C1535926 | |
| Disease | obsolete_red blood cell distribution width | ASXL1 PATZ1 CDH23 FTCDNL1 REXO1 NSD3 CEP170 FZR1 ZNRF3 KDM2B PDS5A RMND1 WNK3 DNAJC13 EP400 KALRN CHAF1A TUT7 TRMT1 BRD3 REST ZFPM2 NKD2 CBX6 MARK4 PCIF1 HSH2D RP1 MYBL2 | 3.96e-06 | 1347 | 249 | 29 | EFO_0005192 |
| Disease | Autistic Disorder | PDE4A KMT2E SYNGAP1 NLGN3 UBE3A ATP10A GZMB DIXDC1 RIMS1 GABBR1 | 8.18e-05 | 261 | 249 | 10 | C0004352 |
| Disease | coronary artery disease | SLK PCNX3 ZNF268 CHD2 AHDC1 TULP1 R3HCC1L ALDH5A1 CUX2 DNAJC13 MAGI3 PPHLN1 REST GOSR2 ZFPM2 FAM83B PPP2R2A CELSR2 MAP1S MARK4 RP1 PAX5 PALLD GABBR1 | 8.27e-05 | 1194 | 249 | 24 | EFO_0001645 |
| Disease | mean arterial pressure | SLK PCNX3 UPF3A REXO1 CEP170 ZNRF3 PDS5A CUX2 GOSR2 POM121C USP8 MARK4 AUTS2 MAPK4 | 9.80e-05 | 499 | 249 | 14 | EFO_0006340 |
| Disease | right ventricular ejection fraction measurement | 1.14e-04 | 30 | 249 | 4 | EFO_0021816 | |
| Disease | creatinine measurement | GAPVD1 OBSCN CHD2 NEB GAB2 B4GALT1 SH3YL1 DUOX1 SVIL PIP5K1A CUX2 DNAJC13 FAM83B ZZZ3 CELSR2 EIF4B SETBP1 DOCK7 ANKRD11 FAM53B RP9 | 1.20e-04 | 995 | 249 | 21 | EFO_0004518 |
| Disease | Malignant neoplasm of breast | TRPC4 RPS9 OBSCN GATA3 LRRC37A BRCA2 MKI67 OSBPL11 RMND1 PRRC2A NIPBL NCOA2 TANK KALRN SMC6 SPTLC1 PPHLN1 NUP214 PANX2 SETBP1 GZMB HNRNPR | 1.26e-04 | 1074 | 249 | 22 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QTPSAKEEEKIQRRP | 711 | Q9UKF5 | |
| FQKLPQASRREERAP | 586 | Q8N715 | |
| RRRTLPQLPNEEKSL | 641 | Q5SW79 | |
| PREEGKSKNNRPLRT | 2431 | Q96L91 | |
| RGPSLIPQIKQEKRD | 186 | Q52LR7 | |
| EASRENSKPRAILKP | 376 | Q00005 | |
| PLSDPKQAKVVARRE | 266 | Q15059 | |
| IRHSRDKKNEPNPQR | 341 | P15291 | |
| ERRELIRSQAVKKNP | 221 | Q9Y2D5 | |
| EISQPQKGRKPRDLE | 306 | P19419 | |
| QHPERQKDKEPRDRR | 1171 | Q6UB99 | |
| NRKVKPREPKRNRII | 161 | O95503 | |
| NDQNLRAPVKKSRRP | 21 | P22674 | |
| ASRENNKPRTVLKPR | 381 | P63151 | |
| RPELVRPALENSLKK | 91 | P42330 | |
| ARPNRNLTFTKKEPL | 571 | Q3SY69 | |
| SRRANRRKEEKLFPP | 901 | P51816 | |
| KRPAVKPVQDLRQDL | 36 | Q155Q3 | |
| RVTKPKIPEAIRRNF | 171 | O75477 | |
| RKAKRTRAVQPLRLP | 116 | P10144 | |
| IRALQKRLREPEKQP | 201 | O00270 | |
| KRLREPEKQPKLQRA | 206 | O00270 | |
| PLPDEDKKVNRQSAR | 886 | Q9P0K1 | |
| QAQKDPKKDRPLARR | 481 | Q13362 | |
| NQRLKVPSPKRRVVC | 366 | P18850 | |
| DKRSLRVPKRPIINT | 2266 | Q9HCU4 | |
| PKDTKFNPKTRREIR | 181 | Q8IU60 | |
| KRRRRKQKLASPQPS | 586 | Q5TGY3 | |
| IKPEKRPRRVNREVV | 51 | Q9HCK5 | |
| PAQEEQTPKASKRER | 716 | Q13111 | |
| RASRDLLKEFPQPKN | 41 | Q7L2E3 | |
| KRNPELLSPKEQREG | 136 | O14529 | |
| ISVKDNPENPRIARR | 1926 | Q9H251 | |
| RLKVQLKRPKDANRP | 466 | Q96J87 | |
| GEKEERPRQQDPQRK | 101 | A6NDY2 | |
| PEKKPRLEDRQSFRN | 536 | Q8IXJ9 | |
| PDQPRTKVRVRFELK | 586 | O60312 | |
| FPERRCRNIKKPNLD | 1091 | Q8TE60 | |
| LARLRQENKPKLVPS | 181 | Q96K21 | |
| NPKIKRDERTLINPD | 306 | P49759 | |
| PKDQPQEGRKSKRRV | 71 | Q2M1V0 | |
| QEPLARTKRRPIVKT | 91 | O95156 | |
| RPKLLRLVKERPQTN | 396 | Q9Y3T6 | |
| VFKDKPEARRLNINP | 61 | Q7Z5L2 | |
| NLRPRKTRPLKAENP | 141 | Q8IXT5 | |
| QPKARQRRKPRVLFS | 126 | A6NCS4 | |
| REIARKLANPKQPTN | 591 | Q29RF7 | |
| ERAQKSEPREGQKLP | 211 | Q9Y388 | |
| FIQRKISRPSQRPKT | 406 | P43630 | |
| DDGLIPQRKSRKPEN | 406 | H3BUK9 | |
| QEAEAEKPRKPKRQR | 811 | F8W0I5 | |
| ESEPDLPLKRKQRRS | 206 | P23759 | |
| KRKRDEGIQESPVPN | 196 | Q02548 | |
| DTDPPQEIRRRFGKK | 991 | Q9NRD9 | |
| GEKEERPRQQDPQRK | 101 | A8MXZ1 | |
| RAADPAPEVRKVNRI | 406 | Q8IVT2 | |
| RPVPQESSRKNAKEA | 1036 | Q13127 | |
| QPKNPRELHRRRKLD | 76 | Q9NUD7 | |
| EVALRQENKRPSPRK | 186 | Q9Y4B6 | |
| TEEERAQRPRLQLKP | 201 | Q15056 | |
| PPVQRKSEDRTQLKG | 311 | Q9BW71 | |
| PDVNQSPRGKRRAKA | 151 | Q8WXG6 | |
| VARKEPARAEAPRKT | 501 | Q66K74 | |
| SPLKNNPKRRPRDQS | 1241 | Q5TCQ9 | |
| SKKKPPVETRRNRER | 91 | Q3KP22 | |
| QPSRRPAKLKIRKQC | 356 | Q6NUN7 | |
| PAKALPQVRDRSKDL | 1261 | A6NMS7 | |
| AEPTRQQPSKRRKRK | 286 | Q86U70 | |
| RAKRDLPKRTATQRP | 326 | Q96FI4 | |
| IRNATKLRVSPKNPR | 511 | O00533 | |
| PNIKRVTPQRKVFRS | 121 | Q14703 | |
| QATRVPTPKRKNLVA | 191 | A0A1B0GTS1 | |
| SPVPVRKNSRDEEKR | 576 | Q9NRM7 | |
| RQNPLEPKNKARFSI | 71 | Q8NHJ6 | |
| RPQDGLRLKSKEPRE | 3026 | Q9UKN7 | |
| DRTTVEVKPDPRKNN | 776 | Q8IZA0 | |
| KRPLRKLLPEVNSEA | 271 | P31152 | |
| DPAVPVKNLKRQDAR | 346 | Q9UBS5 | |
| PRNPKTDKLVNERLI | 836 | P05023 | |
| QSKPRQIKRPLEDAI | 6 | Q8WW38 | |
| PANKKNRLPIATRSR | 471 | Q14C86 | |
| KEIKPRLSRNCREDP | 81 | Q86SG4 | |
| SQKERKSLPAPVAQR | 91 | Q5JVS0 | |
| STLTRNRVRQPEKPK | 686 | Q5T0W9 | |
| GEKEERPRQQDPQRK | 101 | A8MWA6 | |
| GEKEERPRQQDPQRK | 101 | P0C7W9 | |
| KRRRPEEVQEQRPSL | 281 | Q14153 | |
| ELAQAQAPKKRRRPE | 16 | Q8N3Y1 | |
| VRPKDLALLRPSKRQ | 381 | Q9H6A9 | |
| AKKPPLRTAADVIQR | 81 | Q96B70 | |
| PLVNTLQRRKEKREP | 421 | O43312 | |
| LKRRTVANPNQRLPK | 116 | P23409 | |
| ENNLNPKPPRRKSRR | 1041 | Q13370 | |
| KEREKQQAPRPRPSQ | 306 | P27815 | |
| NQVVQKERPPRRRES | 791 | O60447 | |
| KLLPPSEKRTNRRNN | 631 | Q1KMD3 | |
| PPDKKRKERQAARQA | 411 | O43390 | |
| RRKHQNDVRPIPNVK | 2961 | O60229 | |
| AEAQQLPKPKRRRLS | 401 | E9PQR5 | |
| IKPPSIERLRETRKN | 486 | Q5T2T1 | |
| PRLKSERAEALKQRP | 791 | Q6KC79 | |
| VALKPQERVEKRQTP | 106 | Q8WXX7 | |
| LARQAPKPRKQRSSL | 51 | P81605 | |
| KQRQTPRKGEPERDK | 646 | P55160 | |
| RKQAPEPLRAEARVA | 421 | P48681 | |
| PFLSEKRRRKEPTEN | 796 | Q8IZD2 | |
| QLRNFLAKRKTPPVR | 946 | P35658 | |
| QVIRERDTKLPKPQL | 361 | Q8IWU2 | |
| QEAEAEKPRKPKRQR | 1016 | A8MRT5 | |
| SKEPPNKRQNARLRV | 56 | O14653 | |
| IPDPRNLTKQKTRTV | 201 | P05129 | |
| RKQRRKQARLVLQPP | 316 | Q9Y2D4 | |
| RKSTEFPRKIREQEP | 106 | P46013 | |
| STRRQPKTPLEKRDV | 1386 | P46013 | |
| DTPASTKQRPKRNLR | 2351 | P46013 | |
| SRRQPRAPKEKAQPL | 2901 | P46013 | |
| RKPIPRDKVTENKRC | 3141 | P46013 | |
| GEKEERPRQQDPQRK | 101 | P0DV74 | |
| VEQSPKPKRQREAEA | 371 | O75200 | |
| REAEAQQLPKPKRRR | 381 | O75200 | |
| SNGTEDPKRQLPRKR | 651 | Q9BZ72 | |
| QEAEAEKPRKPKRQR | 1021 | C9JG80 | |
| RRLVKKPERQQVPTR | 156 | Q9UI10 | |
| GEKEERPRQQDPQRK | 101 | P0DV73 | |
| QATRVPTPKRKNLVA | 191 | A0A1B0GWH4 | |
| TRQIKPLTQKEPVRA | 431 | O95402 | |
| RRARDKQELPNGDPK | 41 | Q969F2 | |
| VEQSPKPKRRRADEV | 366 | A6NHN6 | |
| KPKRRRADEVEQSPK | 371 | A6NHN6 | |
| RADEVEQSPKPKRQR | 376 | A6NHN6 | |
| EAEAQQLPKPKRRRL | 391 | A6NHN6 | |
| KRRASQKEREKPLPT | 266 | Q99755 | |
| KRRPKCREREPLQTA | 991 | Q8WXE0 | |
| GEKEERPRQQDPQRK | 101 | P0DV76 | |
| QAPKDRKVPTRKAER | 281 | Q96JZ2 | |
| RSQTPERPAKKIREE | 421 | A8CG34 | |
| APELKAQEPLRKQSR | 461 | Q86UR5 | |
| NKAKPAPRTQRTINR | 36 | Q75N03 | |
| RKLLSREKQPPIDNI | 101 | P52292 | |
| PRPKFKTRLQSLEQE | 4066 | Q5VST9 | |
| PPSREDRNAKRSTKQ | 536 | O94913 | |
| RKFEADPLPENIRKQ | 271 | Q8TCG2 | |
| IQDSPDFRILQKKPR | 481 | Q8WX93 | |
| DPDGPRKRSRTRKQV | 341 | Q9HBE1 | |
| GEKEERPRQQDPQRK | 101 | A6NJQ4 | |
| YRKDKRRQEPLRQPS | 731 | Q9NZ94 | |
| LENQPPRISKAQKRR | 91 | Q8N6M0 | |
| QNRPLIKPKRRLSAA | 296 | P23771 | |
| QTEDRRLQPSTPEKK | 111 | Q9UM11 | |
| RAKPFRDKPVTDQQL | 506 | B1AJZ9 | |
| LANKPLRRFKQEPED | 881 | Q8NHM5 | |
| LAEKKARSLDRPQAP | 11 | P0C671 | |
| AENKPRKRQLSEEQP | 106 | Q9H4Z3 | |
| NDKLEAPRKSRFPER | 1026 | Q96N67 | |
| NVSKILPRVDKRNPE | 2101 | P51587 | |
| APQRLIRPKQKVADS | 816 | Q5THR3 | |
| DFSNLPPEQRRKKLQ | 401 | Q96RU3 | |
| LRKRRPNIQNPKSQE | 541 | P54289 | |
| EQKKVKARRPVPRRT | 171 | O14647 | |
| DPQSVPDRLRIRVNK | 716 | O75912 | |
| QQRSKRAAPALEKPI | 506 | Q8IZJ3 | |
| EDEILNRSPRNRKPR | 576 | P27824 | |
| EKPKRRRQEKQAACP | 321 | Q92771 | |
| KREQEPTERPLKGIQ | 171 | Q9BTC0 | |
| RDQDNAIIRPLPKVK | 1061 | O75165 | |
| TKLKRPNQERRNLVP | 191 | Q8NA82 | |
| KRPNVSPKVRELLEQ | 86 | Q9NX58 | |
| PPDRKLSKNEVLRLA | 181 | P12980 | |
| NPNKAEIPERRKDST | 481 | Q96L34 | |
| PRNPRTDKLVNERLI | 826 | P13637 | |
| RDLEIRKQDTKSPRP | 631 | Q8NEP3 | |
| RKQDTKSPRPLIQEL | 636 | Q8NEP3 | |
| IPEKNRPLKDRINLV | 61 | Q86XF0 | |
| DQRLLIKNPRTKPRT | 281 | Q9UH77 | |
| SQRPEVQKPRRARQK | 46 | A0A183 | |
| ADLPEKRSLVQRRKQ | 91 | E5RQL4 | |
| PPNALRISKEVIRKR | 341 | O75521 | |
| GEKEERPRQQDPQRK | 101 | A6NIJ5 | |
| GEKEERPRQQDPQRK | 101 | A8MXJ8 | |
| SPKPKRRRVDEVEQS | 371 | E9PJ23 | |
| RRRVDEVEQSPKPKR | 376 | E9PJ23 | |
| QREAEAQQLPKPKRR | 391 | E9PJ23 | |
| NPERDKERPVQSLKT | 186 | Q8NEY8 | |
| KVRVRKDSSDRENPP | 786 | Q92613 | |
| VEQSPKPKRQREAEA | 386 | F8W1W9 | |
| REAEAQQLPKPKRRR | 396 | F8W1W9 | |
| GEKEERPRQQDPQRK | 101 | P0C7X0 | |
| TVPQKPRQVADAREK | 106 | Q9BY77 | |
| QEAEAEKPRKPKRQR | 1021 | A6NJU9 | |
| RVENSKAEKPKPARR | 451 | Q96RD6 | |
| KRVRPLEKQDPFESR | 661 | Q9BXB4 | |
| KLQRQLDEPKLERRP | 386 | P23588 | |
| KKEVPERSLERNRPK | 486 | Q92833 | |
| VKSPQENLREPKRKR | 246 | Q9BVI0 | |
| VPLKRPRLDKNSSQE | 296 | Q9BVI0 | |
| KVQPVDLDKARRRPR | 111 | P56715 | |
| RAKNIRNKPRINEDP | 331 | Q9P2E2 | |
| RNKPRINEDPKDALL | 336 | Q9P2E2 | |
| EREDNRKCPPSILKR | 36 | Q8N912 | |
| PSKQELEDRNIFPRR | 411 | Q96KR7 | |
| DLKQPVLVSQPKRRR | 356 | Q96J94 | |
| RKAKPTPLDLRNNTV | 521 | Q9UQC2 | |
| KVRREPKNLSDIRGP | 61 | Q9NX20 | |
| PRRPFEKSRLDQELK | 16 | P46781 | |
| KLVLPSRPRKLQEAQ | 456 | Q4VX76 | |
| PAASTDPNIVRKKER | 196 | Q5H9L4 | |
| AARKTRVEANSPLPK | 16 | Q9H7C4 | |
| VKTEDRGRLARQPPK | 626 | Q8N1G1 | |
| RGRLARQPPKEEKSE | 631 | Q8N1G1 | |
| RLLQNKRKEPPEDVA | 581 | Q9NXH9 | |
| KRKEPPEDVAQRAAR | 586 | Q9NXH9 | |
| PLRKAAVRQQKAPQE | 366 | Q9Y6A5 | |
| PPEQELQRRREQKRR | 21 | Q8TA86 | |
| QERARLPKIQRSEAK | 1066 | Q9H2G2 | |
| LNQINKASPRRLPRK | 261 | P43307 | |
| TPAKDRRALVLKQPI | 181 | P51649 | |
| SPEPQDQKKPRNRRH | 766 | Q13275 | |
| RAKKRLRQSGEELPP | 211 | O75391 | |
| AVRPKRRVQASKNPL | 1351 | O95425 | |
| QERKAVTKRSPEAPQ | 266 | P14317 | |
| LRNSTDLQEPRPRAK | 91 | P58417 | |
| PPSVLKRQRKRRVAL | 406 | P10244 | |
| DDGLIPQRKSRKPEN | 406 | A0A0A6YYL3 | |
| PRKERLANKDRPALQ | 426 | Q9H1J1 | |
| GEKEERPRQQDPQRK | 101 | A8MX19 | |
| GEKEERPRQQDPQRK | 101 | A6NNJ1 | |
| GEKEERPRQQDPQRK | 101 | P0C7W8 | |
| GEKEERPRQQDPQRK | 101 | D6RGX4 | |
| RKPEKEPRRSGRATN | 41 | Q96QT6 | |
| AAREQRKSSAKELPP | 226 | Q96HL8 | |
| QDKPPRFRRLKQERE | 1251 | P48634 | |
| EKLDRKAPSRINNPE | 81 | Q9Y371 | |
| KRAPPVRVDEEKRQQ | 6 | Q149N8 | |
| FPQVKRPLKASRTRQ | 141 | Q9NWS8 | |
| RVDNIIKAAPRKRVP | 516 | P78371 | |
| KLPKVRRQEVSSPRK | 106 | Q92844 | |
| QRAKELNKRLTAPPA | 56 | Q9H9Q4 | |
| PDVARREQNTKRDIP | 3701 | Q9P2P6 | |
| KDDLRKISDLRIPPN | 176 | Q8IYB8 | |
| RREQLPPQEDSKVTK | 401 | Q8NE31 | |
| KSRPLRVRDNSAPAK | 296 | E7EW31 | |
| DPNRAVPLRKRKVKA | 61 | Q9Y3C1 | |
| GEKEERPRQQDPQRK | 101 | P0C7V4 | |
| IEDQKNPRKARVTRR | 226 | O15269 | |
| PPSAKLRRNALKEIV | 156 | Q5VYV7 | |
| KELDRFGVRPLPKRQ | 1576 | Q8IY92 | |
| RLKVQLKRPKDANRP | 471 | Q9BZC1 | |
| PEQRKRSKSLDSRLP | 206 | Q9P2M7 | |
| PENESPLEQKLRKLR | 86 | Q96IL0 | |
| LGPSPKRNTEKRNRE | 26 | Q15596 | |
| EAERRKQKQRLTPRP | 1686 | Q7KZ85 | |
| APAQRLRKKRTEAPE | 36 | O00294 | |
| LREKNSVIRSLKRPP | 426 | O15417 | |
| KELAKRQRLPSVENR | 2761 | O15417 | |
| RQRLPSVENRPKIAA | 2766 | O15417 | |
| RKPVAVLKRPSQLSR | 151 | Q96QD9 | |
| LAARLEPPEQRKKTI | 206 | Q9H4B4 | |
| SIEARKSPKLPRAAQ | 546 | Q9NRJ4 | |
| RQRKLLAKRKPPTAN | 341 | Q9UKI8 | |
| PPQRTRKTCIRRNKV | 86 | Q9Y676 | |
| LPSRDTALPQERNKK | 71 | Q8NHY6 | |
| KRNAVLPSKPLQDRE | 236 | Q9ULJ3 | |
| QKDKDLQTRRPPQRR | 736 | Q9BYN7 | |
| ERRNKKGPRVDPLET | 416 | Q05086 | |
| PGTPRQKQKSRRIEK | 46 | Q14587 | |
| TPAIKTQRPKVRIQD | 31 | Q13156 | |
| RSQLQELREKLRPPA | 176 | Q8N9B8 | |
| EPKKRLLDAQERQLP | 1286 | Q96PV0 | |
| FQQPEKPGRVRRRKT | 11 | A6NJB7 | |
| SRPSKRQPDQIRKQE | 96 | A0A1B0GVG6 | |
| KDKRIRVSQPLTRGP | 26 | P58005 | |
| LRVRPREQKEFQSPA | 121 | Q9H6E5 | |
| AKRANIRLPPEVNRI | 6 | Q9Y3B4 | |
| QALAPESRALRKDKP | 66 | Q07617 | |
| RKRGPRIPKDENINF | 586 | P23497 | |
| GEKEERPRQQDPQRK | 101 | Q658T7 | |
| PGSRELKRREKPQQS | 226 | P58340 | |
| PEKNLQPRQRRSSKS | 666 | Q92576 | |
| QPERPRDVKLARTQL | 171 | P13686 | |
| SPKNAKRPRQEELED | 11 | Q96SB8 | |
| PVRRRPAEEELKTKN | 331 | Q6ZSY5 | |
| SEKQKIRKPRPQRER | 351 | Q9BZ95 | |
| VKKTRRPRSVLNTQP | 416 | Q9BZ95 | |
| KRRTESRPLPNKLNA | 251 | Q6IQ21 | |
| RDNVSRKDRVPKCPE | 371 | Q9Y577 | |
| QFNDLSIDLPRRKKP | 501 | Q86T82 | |
| NKQKVARARIQHRPP | 196 | Q9ULT6 | |
| KVVDRRRAPPDFVNK | 41 | Q9BXA6 | |
| EQLNRKRERRPLPKN | 181 | Q63HK3 | |
| RDRQRSPIALPVKQE | 206 | Q8TF01 | |
| LRNPPRRQLKKLDED | 6 | Q13043 | |
| SQPAEDRRRVRAPKK | 6 | H3BQB6 | |
| ELNAPIRRNKEEPKA | 231 | Q9NZ63 | |
| IRRNKEEPKARPLRV | 236 | Q9NZ63 | |
| RPRKPRKTRNEENEQ | 181 | Q5VYS8 | |
| RKLKRQNREDTALPP | 861 | Q8IWV8 | |
| KKRRGRPRKQPTQFD | 1451 | Q9Y6X0 | |
| QPLPQEEEVKAKRQR | 1571 | Q9Y6X0 | |
| REARSDQVKPEKVPR | 326 | Q8NG27 | |
| KTQPNPKSQARRIRK | 131 | Q96ME7 | |
| RRQTEPVSPVLKRIK | 106 | Q8IYH5 | |
| QIPAERDREPSKLKR | 701 | P40818 | |
| DRNKRIKPRPERFQN | 86 | Q9NP77 | |
| SALVVQEPPREKQRK | 821 | Q9UBN4 | |
| RQREKRDKPRSTSPA | 306 | Q5T200 | |
| LVKPDNRNCKRPREL | 6 | Q9BXU0 | |
| PRRRSLKKNLVPQIN | 1056 | B1ANS9 | |
| KPPDQKLVVRSSRDN | 21 | Q9Y493 | |
| PEKRTNGLRRTPKQV | 576 | Q9UKW4 | |
| DRIKQRRASCPRPEK | 726 | Q9BYP7 | |
| GEKEERPRQQDPQRK | 101 | P0DV75 | |
| RKLSQKLRELTEQPP | 386 | P23276 | |
| ALAQPASAKPVERRK | 56 | P20929 |